US5451343A - Fluorone and pyronin y derivatives - Google Patents
Fluorone and pyronin y derivatives Download PDFInfo
- Publication number
- US5451343A US5451343A US08/154,880 US15488093A US5451343A US 5451343 A US5451343 A US 5451343A US 15488093 A US15488093 A US 15488093A US 5451343 A US5451343 A US 5451343A
- Authority
- US
- United States
- Prior art keywords
- fluorone
- hydroxy
- cyano
- hydrogen
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- FRIPRWYKBIOZJU-UHFFFAOYSA-N fluorone Chemical compound C1=CC=C2OC3=CC(=O)C=CC3=CC2=C1 FRIPRWYKBIOZJU-UHFFFAOYSA-N 0.000 title description 15
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 78
- 239000001257 hydrogen Substances 0.000 claims abstract description 39
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 39
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 20
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910052721 tungsten Inorganic materials 0.000 claims abstract description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 8
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 88
- -1 hydroxy, amino Chemical group 0.000 claims description 35
- NPKSPKHJBVJUKB-UHFFFAOYSA-N N-phenylglycine Chemical group OC(=O)CNC1=CC=CC=C1 NPKSPKHJBVJUKB-UHFFFAOYSA-N 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 125000006575 electron-withdrawing group Chemical group 0.000 claims description 15
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 9
- 125000002346 iodo group Chemical group I* 0.000 claims description 7
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 239000000460 chlorine Chemical group 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 239000011593 sulfur Chemical group 0.000 claims description 4
- 125000000520 N-substituted aminocarbonyl group Chemical group [*]NC(=O)* 0.000 claims description 3
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical group [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- OZLBDYMWFAHSOQ-UHFFFAOYSA-N diphenyliodanium Chemical class C=1C=CC=CC=1[I+]C1=CC=CC=C1 OZLBDYMWFAHSOQ-UHFFFAOYSA-N 0.000 claims description 2
- HDCXQTPVTAIPNZ-UHFFFAOYSA-N n-({[4-(aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide Chemical group C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NC1=CC=C(S(N)(=O)=O)C=C1 HDCXQTPVTAIPNZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 239000011669 selenium Chemical group 0.000 claims description 2
- 229910052714 tellurium Inorganic materials 0.000 claims description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical group [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 claims description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 abstract 1
- 101150035983 str1 gene Proteins 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 62
- 230000015572 biosynthetic process Effects 0.000 description 52
- 238000003786 synthesis reaction Methods 0.000 description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 49
- 239000000243 solution Substances 0.000 description 32
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 31
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 27
- 239000002244 precipitate Substances 0.000 description 27
- 239000011541 reaction mixture Substances 0.000 description 21
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- POARTHFLPKAZBQ-UHFFFAOYSA-N 3,6-dihydroxyxanthen-9-one Chemical compound OC1=CC=C2C(=O)C3=CC=C(O)C=C3OC2=C1 POARTHFLPKAZBQ-UHFFFAOYSA-N 0.000 description 16
- 239000007787 solid Substances 0.000 description 11
- 150000008377 fluorones Chemical class 0.000 description 10
- 239000011630 iodine Substances 0.000 description 10
- 229910052740 iodine Inorganic materials 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 230000004927 fusion Effects 0.000 description 8
- 239000003999 initiator Substances 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 7
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 238000003018 immunoassay Methods 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 6
- PDYQQADWTNPTRK-UHFFFAOYSA-N 9h-xanthene-3,6-diol Chemical compound C1=C(O)C=C2OC3=CC(O)=CC=C3CC2=C1 PDYQQADWTNPTRK-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 6
- 102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 6
- 101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 125000004093 cyano group Chemical group *C#N 0.000 description 6
- 239000001021 fluorone dye Substances 0.000 description 6
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 6
- 125000005647 linker group Chemical group 0.000 description 6
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- JZMPIUODFXBXSC-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.OC(=O)C=C.CCOC(N)=O JZMPIUODFXBXSC-UHFFFAOYSA-N 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000010937 tungsten Substances 0.000 description 4
- XAXSPYAXUNVJBL-UHFFFAOYSA-N 3,6-dimethoxyxanthen-9-one Chemical compound COC1=CC=C2C(=O)C3=CC=C(OC)C=C3OC2=C1 XAXSPYAXUNVJBL-UHFFFAOYSA-N 0.000 description 3
- YFYUNKAICYPTDQ-UHFFFAOYSA-N 3-butoxy-6-hydroxyxanthen-9-one Chemical compound OC1=CC=C2C(=O)C3=CC=C(OCCCC)C=C3OC2=C1 YFYUNKAICYPTDQ-UHFFFAOYSA-N 0.000 description 3
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical group ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 235000011089 carbon dioxide Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- ICIWUVCWSCSTAQ-UHFFFAOYSA-N iodic acid Chemical compound OI(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-N 0.000 description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 3
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- RSJLWBUYLGJOBD-UHFFFAOYSA-M diphenyliodanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[I+]C1=CC=CC=C1 RSJLWBUYLGJOBD-UHFFFAOYSA-M 0.000 description 2
- UEQLWHWHNVZWAF-UHFFFAOYSA-M diphenyliodanium;hydroxide Chemical compound [OH-].C=1C=CC=CC=1[I+]C1=CC=CC=C1 UEQLWHWHNVZWAF-UHFFFAOYSA-M 0.000 description 2
- 238000007336 electrophilic substitution reaction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 125000001810 isothiocyanato group Chemical group *N=C=S 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical group ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000001429 visible spectrum Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 150000003732 xanthenes Chemical class 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- MEZJQXVOMGUAMP-UHFFFAOYSA-N 1-(2-methylnaphthalen-1-yl)pyrrole-2,5-dione Chemical compound CC1=CC=C2C=CC=CC2=C1N1C(=O)C=CC1=O MEZJQXVOMGUAMP-UHFFFAOYSA-N 0.000 description 1
- ZDQNWDNMNKSMHI-UHFFFAOYSA-N 1-[2-(2-prop-2-enoyloxypropoxy)propoxy]propan-2-yl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(C)COCC(C)OC(=O)C=C ZDQNWDNMNKSMHI-UHFFFAOYSA-N 0.000 description 1
- HUDYANRNMZDQGA-UHFFFAOYSA-N 1-[4-(dimethylamino)phenyl]ethanone Chemical compound CN(C)C1=CC=C(C(C)=O)C=C1 HUDYANRNMZDQGA-UHFFFAOYSA-N 0.000 description 1
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- VOBUAPTXJKMNCT-UHFFFAOYSA-N 1-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound CCCCCC(OC(=O)C=C)OC(=O)C=C VOBUAPTXJKMNCT-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- XWTLWBDPLPQCOR-UHFFFAOYSA-N 2,6-diethyl-n,n-dimethylaniline Chemical compound CCC1=CC=CC(CC)=C1N(C)C XWTLWBDPLPQCOR-UHFFFAOYSA-N 0.000 description 1
- MTPIZGPBYCHTGQ-UHFFFAOYSA-N 2-[2,2-bis(2-prop-2-enoyloxyethoxymethyl)butoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCC(CC)(COCCOC(=O)C=C)COCCOC(=O)C=C MTPIZGPBYCHTGQ-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- XSAYZAUNJMRRIR-UHFFFAOYSA-N 2-acetylnaphthalene Chemical compound C1=CC=CC2=CC(C(=O)C)=CC=C21 XSAYZAUNJMRRIR-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- SSBICDXZFDYLOE-UHFFFAOYSA-N 3,6-dihydroxy-4,5-diiodoxanthen-9-one Chemical compound OC1=CC=C2C(=O)C3=CC=C(O)C(I)=C3OC2=C1I SSBICDXZFDYLOE-UHFFFAOYSA-N 0.000 description 1
- MESJRHHDBDCQTH-UHFFFAOYSA-N 3-(dimethylamino)phenol Chemical compound CN(C)C1=CC=CC(O)=C1 MESJRHHDBDCQTH-UHFFFAOYSA-N 0.000 description 1
- NQGDHQASSFDDLD-UHFFFAOYSA-N 3-[2,2-dimethyl-3-(3-prop-2-enoyloxypropoxy)propoxy]propyl prop-2-enoate Chemical compound C=CC(=O)OCCCOCC(C)(C)COCCCOC(=O)C=C NQGDHQASSFDDLD-UHFFFAOYSA-N 0.000 description 1
- YRIHKEDMSJCAEK-UHFFFAOYSA-N 3-hydroxy-6-methoxyxanthen-9-one Chemical compound OC1=CC=C2C(=O)C3=CC=C(OC)C=C3OC2=C1 YRIHKEDMSJCAEK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- JYMNQRQQBJIMCV-UHFFFAOYSA-N 4-(dimethylamino)benzonitrile Chemical compound CN(C)C1=CC=C(C#N)C=C1 JYMNQRQQBJIMCV-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- XYZWMVYYUIMRIZ-UHFFFAOYSA-N 4-bromo-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(Br)C=C1 XYZWMVYYUIMRIZ-UHFFFAOYSA-N 0.000 description 1
- NOTZHLDTUSLGBM-UHFFFAOYSA-N 4-ethoxy-n,n-dimethylaniline Chemical compound CCOC1=CC=C(N(C)C)C=C1 NOTZHLDTUSLGBM-UHFFFAOYSA-N 0.000 description 1
- SJDILFZCXQHCRB-UHFFFAOYSA-N 4-tert-butyl-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(C(C)(C)C)C=C1 SJDILFZCXQHCRB-UHFFFAOYSA-N 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical class [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 101100476210 Caenorhabditis elegans rnt-1 gene Proteins 0.000 description 1
- 101100172879 Caenorhabditis elegans sec-5 gene Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 101100476756 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) sec-61 gene Proteins 0.000 description 1
- YVTVFZKHLXIJEY-UHFFFAOYSA-N OC(=O)C=C.OC(=O)C=C.C1OC1COCC1CO1 Chemical compound OC(=O)C=C.OC(=O)C=C.C1OC1COCC1CO1 YVTVFZKHLXIJEY-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 101150108015 STR6 gene Proteins 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- VZTQQYMRXDUHDO-UHFFFAOYSA-N [2-hydroxy-3-[4-[2-[4-(2-hydroxy-3-prop-2-enoyloxypropoxy)phenyl]propan-2-yl]phenoxy]propyl] prop-2-enoate Chemical compound C=1C=C(OCC(O)COC(=O)C=C)C=CC=1C(C)(C)C1=CC=C(OCC(O)COC(=O)C=C)C=C1 VZTQQYMRXDUHDO-UHFFFAOYSA-N 0.000 description 1
- FHLPGTXWCFQMIU-UHFFFAOYSA-N [4-[2-(4-prop-2-enoyloxyphenyl)propan-2-yl]phenyl] prop-2-enoate Chemical compound C=1C=C(OC(=O)C=C)C=CC=1C(C)(C)C1=CC=C(OC(=O)C=C)C=C1 FHLPGTXWCFQMIU-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 238000005902 aminomethylation reaction Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- MGFYSGNNHQQTJW-UHFFFAOYSA-N iodonium Chemical compound [IH2+] MGFYSGNNHQQTJW-UHFFFAOYSA-N 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- REOJLIXKJWXUGB-UHFFFAOYSA-N mofebutazone Chemical group O=C1C(CCCC)C(=O)NN1C1=CC=CC=C1 REOJLIXKJWXUGB-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- JZBZLRKFJWQZHU-UHFFFAOYSA-N n,n,2,4,6-pentamethylaniline Chemical compound CN(C)C1=C(C)C=C(C)C=C1C JZBZLRKFJWQZHU-UHFFFAOYSA-N 0.000 description 1
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical compound CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 description 1
- NEAQRDZTPALWHN-UHFFFAOYSA-N n,n-dimethyl-2,3-di(propan-2-yl)aniline Chemical compound CC(C)C1=CC=CC(N(C)C)=C1C(C)C NEAQRDZTPALWHN-UHFFFAOYSA-N 0.000 description 1
- XZEJXEZIWLTFJR-UHFFFAOYSA-N n-[4-(dimethylamino)phenyl]acetamide Chemical compound CN(C)C1=CC=C(NC(C)=O)C=C1 XZEJXEZIWLTFJR-UHFFFAOYSA-N 0.000 description 1
- REEZZSHJLXOIHL-UHFFFAOYSA-N octanoyl chloride Chemical compound CCCCCCCC(Cl)=O REEZZSHJLXOIHL-UHFFFAOYSA-N 0.000 description 1
- 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000003452 oxalyl group Chemical group *C(=O)C(*)=O 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- KCTAWXVAICEBSD-UHFFFAOYSA-N prop-2-enoyloxy prop-2-eneperoxoate Chemical compound C=CC(=O)OOOC(=O)C=C KCTAWXVAICEBSD-UHFFFAOYSA-N 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- WVIICGIFSIBFOG-UHFFFAOYSA-N pyrylium Chemical class C1=CC=[O+]C=C1 WVIICGIFSIBFOG-UHFFFAOYSA-N 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000007342 radical addition reaction Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
- C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B11/00—Diaryl- or thriarylmethane dyes
- C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
- C09B11/10—Amino derivatives of triarylmethanes
- C09B11/24—Phthaleins containing amino groups ; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B11/00—Diaryl- or thriarylmethane dyes
- C09B11/28—Pyronines ; Xanthon, thioxanthon, selenoxanthan, telluroxanthon dyes
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
- G03F7/028—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
- G03F7/028—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
- G03F7/029—Inorganic compounds; Onium compounds; Organic compounds having hetero atoms other than oxygen, nitrogen or sulfur
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
- G03F7/028—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
- G03F7/031—Organic compounds not covered by group G03F7/029
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/038—Macromolecular compounds which are rendered insoluble or differentially wettable
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/075—Silicon-containing compounds
- G03F7/0755—Non-macromolecular compounds containing Si-O, Si-C or Si-N bonds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S430/00—Radiation imagery chemistry: process, composition, or product thereof
- Y10S430/1053—Imaging affecting physical property or radiation sensitive material, or producing nonplanar or printing surface - process, composition, or product: radiation sensitive composition or product or process of making binder containing
- Y10S430/1055—Radiation sensitive composition or product or process of making
- Y10S430/114—Initiator containing
- Y10S430/115—Cationic or anionic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S430/00—Radiation imagery chemistry: process, composition, or product thereof
- Y10S430/1053—Imaging affecting physical property or radiation sensitive material, or producing nonplanar or printing surface - process, composition, or product: radiation sensitive composition or product or process of making binder containing
- Y10S430/1055—Radiation sensitive composition or product or process of making
- Y10S430/114—Initiator containing
- Y10S430/122—Sulfur compound containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S430/00—Radiation imagery chemistry: process, composition, or product thereof
- Y10S430/1053—Imaging affecting physical property or radiation sensitive material, or producing nonplanar or printing surface - process, composition, or product: radiation sensitive composition or product or process of making binder containing
- Y10S430/1055—Radiation sensitive composition or product or process of making
- Y10S430/114—Initiator containing
- Y10S430/124—Carbonyl compound containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S430/00—Radiation imagery chemistry: process, composition, or product thereof
- Y10S430/1053—Imaging affecting physical property or radiation sensitive material, or producing nonplanar or printing surface - process, composition, or product: radiation sensitive composition or product or process of making binder containing
- Y10S430/1055—Radiation sensitive composition or product or process of making
- Y10S430/114—Initiator containing
- Y10S430/126—Halogen compound containing
Definitions
- the present invention relates to a novel class of compounds which absorb light at wavelengths greater than 350 nm and are useful as fluorescers or as photoinitiators.
- the present invention provides compounds of the formulas (I) and (II) and their equivalents (the nomenclature of the compounds used herein is based on the numbering of positions as shown in formula (I)): ##STR2## where R 1 , R 2 , R 5 and R 6 are the same or different and represent a hydrogen atom or a halogen atom and R 1 and R 2 may combine to form a ring; R 3 and R 4 are the same or different and represent a hydrogen atom, a halogen atom, a benzoyl group, a group of the formula --L(CH 2 ) n R 8 where n is 1 to 8, R 8 is hydrogen, hydroxy, amino, dialkylamino, --COR 16 , or --COOR 14 where R 16 is hydrogen, chlorine, COCl, C1-C8 alkyl,
- a further embodiment of the invention is ionically bonded complexes of the aforesaid compounds in which W is O and W 1 is --OR 9 and one or two iodonium cations.
- W 1 is O - as in TIHF below
- the compounds are believed to form ionic complexes with iodonium cations at the 3- and 6-positions in a ratio of 2 cations per complex.
- W 1 is not O - as in an alkoxy group as in DIBF below, the compounds are believed to form ionic complexes with an iodonium cation at the 6-position in a ratio of 1 cation per complex.
- the compounds of the invention absorb visible light or infrared radiation and fluoresce or act as electron donors or electron acceptors in photoinitation.
- the addition of a strong EWG at the 9 position corresponding to A extends the wavelength of maximum absorption approximately 100 nm to longer wavelengths.
- the compounds of the invention more particularly include fluorone and pyronin Y derivatives of the formula the (III) and (IV): ##STR3## where A is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, dichlorotriazinylamino, and electron withdrawing groups (EWG) which are stronger electron withdrawing groups than a phenyl group or a halogen-substituted or a carboxyl-substituted phenyl group; Y 1 is oxygen, sulfur or >NR 13 where R 13 is 4-methylphenyl; R, and R 1 -R 4 are defined as above; Z is a counter ion and W 2 is hydrogen or --OR 9 and R 9 is defined as above.
- A is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, dichlorotriazinylamino, and electron withdrawing groups (EWG) which are stronger electron withdrawing groups than a phenyl group or
- the compounds of the invention can be more specifically represented by the formula (V): ##STR4## where R 1 -R 4 may be the same or different and are defined as above; EWG is an electron withdrawing group selected from the group consisting of COOR 11 , COR 12 , C(O)OCOR 11 , CONR 2 , CN NO 2 , NCS, NCO SO 2 R 12 , SO 3 R 11 , SO 2 NR 2 , CX 3 2 ; R 11 is hydrogen, alkyl, aryl, or aralkyl; R 12 is hydrogen, alkyl, aryl, or aralkyl, X 2 can be the same or different and is a halogen atom; and W and W' are selected from the group consisting respectively of ⁇ O and O-- and ⁇ NR 2 + and --NR 2 where R is defined as above.
- R 3 and R 4 may be a linking group (for example R, R 11 or R 12 as defined above may be, N-imido such as N-succinimido and N-maleimido, or NR 2 ).
- R 11 is N-imido or --NR 2 the compounds are esters of N-hydroxyimides such as N-hydroxysuccinimides or N-hydroxyamines.
- At least one and preferably at least two of R 1 -R 6 is a halogen atom and more particularly an iodine or bromine atom.
- A is hydrogen or cyano in a particularly preferred class of photoinitiators.
- W 1 is preferably butoxy or octyloxy.
- R 10 is an acrylolyl or methacryloyl group, a polymerizable initiator is provided.
- R 1 -R 6 cannot be bromine or iodine and R 9 must be hydrogen when W 1 is --OR 9 .
- R 4 may be a moiety which produces intramolecular ionization of the compound at W/W 1 .
- R 3 -R 4 will have a basic functional group when W/W 1 is O/O - and have an acid functional group when W/W 1 is NR 2 +/NR 2 . Examples of such moieties are acetyl and amino groups.
- the compounds may be linked to an antibody or a ligand analog for use in immunoassays.
- A, R 3 or R 4 includes a functional group (hereafter a "coupling group") such as an amino group, a carboxyl group, a tert-butoxycarbonyl group (TBOC), a sulfinyl group, a sulfonyl group, an isocyanato group, an isothiocyanato group, a halogen atom, an N-hydroxysuccinimide ester or a N-hydroxy maleimide ester, etc. which enables the compound to be coupled with a ligand analog, an antibody or similar substrate.
- a functional group such as an amino group, a carboxyl group, a tert-butoxycarbonyl group (TBOC), a sulfinyl group, a sulfonyl group, an isocyanato group, an isothiocyanato group, a halogen
- the compounds may be substituted with one or more oleophilic moieties which make the compounds soluble in oil and useful as fluorescent dyes for oil leak detection or as oil soluble photoinitiators.
- the oil solubility of the compounds can be tailored to a particular application by the addition of longer chain, e.g., C4-C8 groups at one or more of R 3 , R 4 and W 1 .
- the compounds may be substituted at R 3 , R 4 and W 1 by alkyl, alkylcarbonyl, carboxyalkyl or alkylcarboxyalkyl groups.
- R 3 and/or R 4 may be substituted by t-butyl or longer chain substituted or unsubstituted alkyl.
- alkyl groups at the 2 and 7 positions extends absorption in the red at least an additional 20 nm, increases the fluorescence quantum yield, and decreases the bleaching rate.
- the invention also provides tracers useful in immunoassays of the formula (VI): ##STR5## where Y 2 is a linking group and A' is a ligand-analog as defined in U.S. Pat. No. 4,585,862 or an antibody, and EWG is defined as above. U.S. Pat. No. 4,585,862 is incorporated herein by reference.
- the linking group Y 2 is the divalent analog of one of the aforesaid functional groups defined for EWG, R 3 or R 4 .
- linking groups include an oxalyl group, a sulfonyl group, a sulfinyl group, a hydroxyimido ester group, a group of the formula --(CH 2 ) n --R 15 where R 15 is oxalyl chloride, carbonyl chloride (COCl), nitrobenzoate ester (e.g., a 2,4-dinitrophenyloxycarbonyl), N-hydroxyimido groups, TBOC esters, or a carboamidosulfonyl or a carboamidosulfinyl group.
- R 15 is oxalyl chloride, carbonyl chloride (COCl), nitrobenzoate ester (e.g., a 2,4-dinitrophenyloxycarbonyl), N-hydroxyimido groups, TBOC esters, or a carboamidosulfonyl or a carboamidosulfinyl group.
- the antibody or ligand-analog may be linked to the tricyclic nucleus via the moiety X 3 in formula (VII) below.
- linkage may be via the A moiety at the 9-position.
- One compound which may be useful in immunoassays is substituted by hydrogen at the 9-position and cyano, isocyanato or isothiocyanato at one of the 2, 4, 5 and 7 positions.
- alkyl groups referenced with respect to the compounds of formula (I)-(VI) above are straight chain, branched chain and cyclic alkyl groups having 1 to 10 carbon atoms.
- aryl groups include phenyl groups which may be unsubstituted or substituted by alkyl, (CH 2 ) p COOR 11 , (CH 2 ) p X 2 , (CH 2 ) p NR 2 , where R, R 11 and X 2 are defined as above and p is 0 to 6.
- aralkyl groups include aralkyl groups containing 7 to 20 carbon atoms such as benzyl, phenethyl, etc.
- alkaryl groups include alkaryl groups containing 7 to 20 carbon atoms such as phenyl substituted at the ortho or para position by a straight chain or branched chain alkyl group having 1 to 6 carbon atoms.
- alkenyl groups include alkenyl groups having 2 to 10 carbon atoms such as vinyl, allyl, 1-propenyl, 1-butenyl and 1,3-butadienyl.
- alkynyl groups include alkynyl groups having up to 10 carbon atoms such as 1-propynyl, 1-butynyl, etc.
- acyl groups are groups of the formula --OCR where R is alkyl or p-aryl such as methyl or phenyl.
- halogen atoms include fluorine, chlorine, bromine and iodine and, more particularly, fluorine or chlorine in the case of fluorescers and bromine or iodine in the case of photoinitiators.
- electron withdrawing groups include COOR 11 , COR 12 , C(O)OCOR 11 , CONR 2 , CN, NO 2 , NCS, NCO, SO 2 R 12 , SO 3 R 11 , SO 2 NR 2 , CX 32 where X 2 , R 11 and R 12 are defined below.
- N-imido refers to groups such as N-maleimido and N-succinimido.
- R 1 and R 2 combine to form a ring
- the compounds in accordance with the invention can be represented by the formula VII. ##STR6## where EWG, R 3 and R 4 are defined as above, n is 2 or 3, and X 3 is >NH, >NR 13 , O, S, PR 17 , CHR 17 where R 17 has the same definition as R 3 -R 4 but can be the same as or different than R 3 -R 4 and may additionally represent dichlorotriazinyl.
- Z Representative examples of the counter ion represented by Z include chloride, bromide, iodide, perchlorate when Z is an anion and monovalent ions such as K + , Na + , ammonium, phosphonium, etc. when Z is a cation.
- W/W' is O/O -
- Z may be hydrogen.
- photoinitiators in accordance with the invention include:
- fluorescers in accordance with the invention include:
- Compounds 37, 37a, 37b, 39 and 40 are 7-carboxy derivatives which can be converted to the N-hydroxysuccinimide ester, the N-maleimide, the t-BOC ester or the acid chloride to introduce linking groups therein.
- compounds which absorb at wavelengths greater than 450 nm and preferably greater than 550 nm. In most compounds, these longer wavelengths of maximum absorption are believed to be attributable to the presence of a strong EWG at the 9-position. Preferred among these are morieties which extend resonance conjugation such as cyano. This effect is illustrated in the following table for compounds of the formula (I) wherein the substituents are as defined as in the following Table 1:
- the compounds absorb strongly in the range of 650-700 nm.
- Certain more specific embodiments of the invention are fluorescers of the formula (IV) where R is methyl and more particularly, R is methyl and A is hydrogen or cyano; photoinitators of the formula (III) where A is hydrogen or cyano and two or more of R 1 -R 4 are iodo or bromo and preferably iodo and still more preferably compounds of the formula (III) in which R 1 and R 3 are iodo, or R 1 and R 2 are iodo, or R 1 , R 2 and R 3 are iodo, or R 1 , R 2 , R 3 and R 4 are iodo; fluorescers of the formula (III) where R 1 , R 2 and R 3 are hydrogen, A is hydrogen or cyano, and R 4 is substituted to enhance solubility or with a linking group.
- Entries in the table are in the solvents according to the following order.
- 3,6-Dihydroxy xanthone (1,60.7 mmol) was dissolved into hot basic water (Na 2 CO 3 240 mmol in 600 ml water). After the 3,6-dihydroxy xanthone was completely dissolved, the temperature was controlled to 70° C. Isopropyl alcohol (10 ml) was added to the reaction mixture and butyl bromide (180 mmol) was added dropwise. The reaction mixture was stirred rigorously for 72 hours. A white precipitate appeared which was then filtered and washed with water. There was almost no disubstituted compound in the product. This precipitate was dissolved in 3% NaOH, filtered and finally reprecipitated with HCl yielding 90% of 3-butoxy-6-hydroxy xanthone.
- 3,6-Dihydroxy xanthone (1,20 mmol) was dissolved in hot mixture of basic water (80 mmol of Na 2 CO 3 in 100 ml of water) and 50 ml of methanol. After the compound was completely dissolved, a methanol solution of octyl bromide (40 mmol in 50 ml of methanol) was added dropwise and the reaction mixture was stirred rigorously for 120 hours at refluxing temperature. The reaction mixture was cooled to room temperature giving a precipitate. This white precipitate was then filtered, washed with water, and washed with hot hexane to remove the disubstituted side product. 3-Octoxy-6-hydroxy xanthone was obtained in 30% yield.
- DIBF 5,7-diiodo-3-butyoxy-6-fluorone
- the 2- and 7- positions can be functionalized by an electrophilic substitution reaction.
- the 9-position is functionalized by a 1,6-conjugated addition reaction followed by autooxidation. See for example compounds 8 and 9 in Reaction Scheme 1.
- 4,5- derivatives can be prepared from 3-hydroxy-4,5-diiodo-6-fluorone (DIHF) which can be prepared as shown in Scheme 3 and illustrated in Synthesis Examples 27 and 28 below: ##STR9##
- 2-Octanoyl-3,6-dimethoxy xanthane (2 mmol) was dissolved in a mixture of 15 ml of ethanol, 16 ml of ethanol, 16 ml of dichloromethane, 1 ml of water and 0.6 ml of conc. HCl.
- 0.6 g of activated carbon containing 10 wt % of palladium was added. After stirring overnight under a hydrogen atmosphere, the activated carbon was filtered out and washed with chloroform. The solution was washed with water using a separate funnel. The organic solvents were removed under reduced pressure and the remaining 2-octyl-3,6-dimethoxy xanthane was purified using column chromatography. The yield was 83%.
- 3,6-dimethoxy-2-octyl xanthane (1.2 mmol), was dissolved in a mixture of 5 ml of ethanethiol and 20 ml of anhydrous dichloromethane. After cooling in a dry ice/EtOH bath, 6 mmol of aluminum chloride was added. The reaction mixture was stirred gradually warming to room temperature overnight. It was then poured into a mixture of 20 g of ice and 10 ml of conc. HCl. The dichloromethane was removed under reduced pressure. The residue was dissolved in aqueous NaOH solution. The solution was then poured into dilute HCl to obtain a precipitate. The precipitate was finally filtered, washed with water to yield in 94%.
- Example 32 The Product of Example 32 (0.135 mmol) was dissolved in 3 ml of DMF. KCN (0.5 mmol) was added and the reaction mixture was stirred at room temperature. The conversion was monitored with a spectrometer. After 2 hours stirring, the mixture was poured into dilute HCl. The title compound was extracted with chloroform. The chloroform solution was washed with water several times to remove DMF. The chloroform was removed yielding 73% of pure compound.
- 1 H NMR (DMSO): 8.14 ppm(1H,s), 7.44(1H,s), 3.14 (2H, t, 7.0 Hz), 0.8-1.6(15H, m). ⁇ max (in EtOH with K 2 CO 2 ) 630 nm.
- the absorption wavelengths of 7-unsubstituted, 7-octanoyl- and 7-octyl-substituted TICHF were 636 nm, 638 nm and 630 nm, respectively.
- An electron withdrawing acyl group shifted only 2 nm to blue and an electron donating alkyl group shifted 6 nm to red. Substitution on the aromatic ring does not seem to change significantly the maximum absorption wavelength.
- dehydroxyfluorones When W is ⁇ O and W 1 is hydrogen, the compounds are herein referred to as dehydroxyfluorones.
- a proposed synthetic route for dehydroxyfluorones is shown in Scheme 6 below. ##STR12##
- the compounds of the present invention are useful in many of the same applications as conventional photoinitiators and fluorescent dyes.
- they are useful as a substitute for fluorescein dyes and other fluorescent agents in immunoassays and still more particularly in polarization immunoassays of the type described in U.S. Pat. No. 4,585,862.
- the compounds are advantageous because they absorb at much longer wavelengths than conventional fluorescers and this enables the use of inexpensive lasers such as He/Ne lasers to excite the compounds.
- inexpensive lasers such as He/Ne lasers to excite the compounds.
- the compounds of the invention are also useful as fluorescent oil additives for use in engine leak detection.
- the fluorescent dyes used in this process require the use of high powered lamps to excite the dye and in order to produce a sufficient level of fluorescence to detect oil leakage due to the competing absorption of the oil and the oil additives.
- the compounds of the invention absorb at longer wavelengths, less competing absorption is encountered and lower power light sources can be used to detect oil leakage.
- the other components of the oil do not compete as much for the light at longer wavelengths.
- a particularly preferred fluorescer for use in leak detection is 2,7-di-t-butyl-3-hydroxy-6-fluorone, Compound No. 5 in Reaction Scheme 1 above.
- compositions are also useful in applications in which clear or translucent layer is required as in providing protective coatings for decorative surfaces such as wall and floor panels and in applications in which a high depth of cure is desired.
- the fluorone initiators are preferably used in combination with a coinitiator.
- Coinitiators useful in the present invention can be selected from among those known in the art and, more particularly, from known electron donating coinitiators.
- N-phenylglycine (NPG) is a well known and preferred coinitiator. Examples of other useful electron donating coinitiators are discussed in Eaton, D. F., "Dye Sensitized Photopolymerization", Advances in Photochemistry, Vol. 13, pp. 427-486.
- N,N-dialkylanilines are also particularly useful.
- Other tertiary amines such as diethanolamine, triethanolamine, and arylsulfinates can also be used.
- Dialkylanilines appear to function as autoxidizers and are preferably used in combination with an electron donor such as NPG.
- Representative examples of N,N-dialkylanilines useful in the present invention are diisopropyldimethylaniline (DIDMA), 4-cyano-N,N-dimethylaniline, 4-acetyl-N,N-dimethylaniline, 4-bromo-N,N-dimethylaniline, 4-methyl-N,N-dimethylaniline, 4-ethoxy-N,N-dimethylaniline, N,N-dimethylthioaniciidine, 4-amino-N,N-dimethylaniline, 3-hydroxy-N,N-dimethylaniline, N,N,N'N'-tetramethyl-1,4-dianiline, 4-acetamido-N,N-dimethylaniline, 2,6-diethyl-N,N-dimethylaniline, N,N,2,4,6-pentamethylaniline (PMA
- alkyl borate salts such as ammonium and pyridinium salts of tetrahydrocarbyl boranyl anions.
- Useful boranylanions are disclosed in U.S. Pat. No. 4,772,541.
- a free radical addition polymerizable or crosslinkable compound useful in the present invention is an ethylenically unsaturated compound and, more specifically, a polyethylenically unsaturated compound.
- These compounds include both monomers having one or more ethylenically unsaturated groups, such as vinyl or allyl groups, and polymers having terminal or pendant ethylenic unsaturation.
- any unsaturated compound which is convertible to a solid by free radical polymerization is useful herein.
- Such compounds are well known in the art and include acrylic and methacrylic esters of polyhydric alcohols such as trimethylolpropane, pentaerythritol, and the like; and acrylate or methacrylate terminated epoxy resins, acrylate or methacrylate terminated polyesters, etc.
- TMPTA trimethylolpropane triacrylate
- DPHPA dipentaerythritol hydroxypentacrylate
- hexanediol-1,6-dimethacrylate hexanediol diacrylate
- N-vinyl pyrrolidone N-vinyl pyrrolidone
- the monomers may be selected and blended to provide the optimum photographic speed and/or the physical characteristics desired in the product. Monomer selection and blending may also be used to insure adequate solubility of the photoinitiators.
- sensitizers include those known in the art such as anthracene, and its derivatives naphthalene, acetophenone, benzophenone, 2-acetonaphthone, etc.
- Solvents may be necessary to dissolve the photoinitiator if the photoinitiator is not sufficiently soluble in the monomer. Solvents may also be used to shift the absorption spectrum to tune the sensitivity of the composition. Some examples of useful solvents are N-vinylpyrrolidone and nitrobenzene. Other useful solvents can be identified readily.
- compositions in accordance with the present invention will generally fall within the following compositional ranges in parts by weight (based on 100 parts total):
- compositions in accordance with the invention more typically are anticipated to have the following formulation:
- Example 35 Examples of some photosensitive compositions incorporating photoinitiators in accordance with the invention are provided in Example 35.
- compositions were prepared:
- compositions were placed in a test tube and exposed to a broad band light source. The compositions all cured rapidly.
- compositions of the present invention are also useful in a wide variety of other applications including photocurable inks and coatings, photoadhesives, printing plates, printed circuit fabrication, and other applications for photohardenable compositions.
- fluorone dye photoinitiators in this invention is the depth of the cure that is obtainable. This is in contrast to UV photoinitators that causes a "screening" effect which prevents the UV light from penetrating beyond a certain minimum depth, usually several millimeters.
- the fluorone dye bleaches as it photoinitiates and is concommitantly converted into a non-visible absorbing species thus allowing more visible light to penetrate which continues the cure. This cascading bleaching effect permits substantial depth of cure which can easily reach several inches.
- An acrylate monomer mixture was composed of 15 parts urethane diacrylate, 20 parts TPGPA, 40 parts TMPTA and 15 parts DPHPA, and a 20 to 1 weight ratio of NPG coinitiator to DIEF or DIBF fluorone dye.
- dye concentrations 0.01, 0.05 and 0.1 weight, all the formulations cured to a depth of 3 cm in 30 seconds when exposed to a 350 watt tungsten halogen light which provides about 500 mw/cm 2 irradiance.
- the irradiance was increased to about 2 watts/cm 2 cure speed was shortened to 5 seconds for the same depth.
- An acrylate mixture was composed of 60% urethane diacrylate, 30% DPHPA, 10% BDDA, and 0.05 weight % of DIEF or DIBF fluorone dye with 2 weight % of DIDMA.
- the formulation cure to a depth greater than 1 cm in 10 seconds when exposed to a 75 watt tungsten halogen lamp which provided an irradiance of about 260 mw/cm 2 .
- An acrylate mixture was composed of 33% TMPTA, 33% DPHPA, 33% Epoxy acrylate, and 2% of DIDMA with either 0.01, 0.05 or 0.1 weight % of DIEF. All samples cured to a depth greater than 1 cm in 10 seconds when exposed to a 75 watt tungsten halogen.
- An acrylate mixture was composed of 70% urethane diacrylate, 5% DPHPA, 25% BDDA, and 2% DIDMA with either 0.01, 0.03 or 0.1 weight % DIEF.
- the 0.01 and 0.03 samples cured after 2 passes through a 300 watt per inch medium pressure mercury arc lamp at a speed of 50 feet/minute to a depth greater than 3 mm.
- the 0.1 sample cured to a depth of greater than 1.5 mm.
- the fluorones described herein are also useful in ionically polymerizable compositions and more particularly cationically polymerizable compositions.
- the fluorones may be used in combination with onium salts such as iodonium, phosphonium, sulfonium and pyrylium salts.
- Compositions containing onium salts are capable of generating free radicals as well as cations and may be used to provide photohardenable compositions which react by either or both mechanisms.
- the fluorone may react as an electron donor or as an electron acceptor depending upon the nature of the coinitiator and onium salt (if present).
- free radical polymerizable composition such as those illustrated in Example 34, the fluorone is an electron acceptor whereas in compositions such as those illustrated in Examples 35-37 below and in cationic polymerization the fluorone is believed to react as an electron donor.
- Cationically polymerizable compositions based upon onium salts are known in the art as shown in U.S. Pat. Nos. 4,264,703 and 4,307,177 to Crivello, and European Application 0 408 227 A1.
- onium salts useful in the invention can be found in published European Patent Application 0 408227A1.
- the preferred onium salts for use in the invention are diphenyliodonium salts such as diphenyliodonium hexafluorophosphate, arsenates, antimonates, etc., and, more particularly, hexafluoro-antimonate.
- Onium salts of simple anions such as chlorides, bromides, etc. are also useful in free radical polymerizable compositions.
- a particularly preferred onium salt is OPPI below. Addition of a coinitiator such as NPG improves film speed, pencil hardness and double bond conversion.
- a particularly preferred initiator system is a combination of an iodofluorone in accordance with the invention such as TIHF or DIBF, an amine such as NPG or DIDMA and an onium salt.
- an iodofluorone in accordance with the invention such as TIHF or DIBF
- an amine such as NPG or DIDMA
- an onium salt is about 1:2:3. Keeping this ratio constant, the double bond conversion has been observed to increase as the molar concentration of the fluorone increases from 0.001 to 0.003 molar.
- the fluorone may be metathesized with an onium salt to form an ionically bonded complex of one or two onium cations and the fluorone dye anion.
- Complex formation occurs at the 6-position when W ⁇ O as well as at the 3-position when W 1 is O - in formula (III).
- Photosensitive compositions were prepared from the resin formulation of Example 35 containing 1% NPG and 0.05% DIBF or 0.05% DIEF. The samples were exposed under the conditions shown in the following table and pencil hardness was measured. The results are shown in Table 6.
- Samples were also prepared using 1% DIDMA in addition to the fluorone for a 20:1 weight ratio.
- the exposure conditions and pencil hardness are shown in the following Table 8.
- Samples were also prepared from the same resin formulation containing 0.1% DIBF in addition to the coinitiator listed in the following Table 9 with the exposure condition and pencil hardness results shown.
- photosensitive compositions were prepared using TIHF, DIDMA and OPPI at a concentration of 0.21% and in the molar ratios shown in Table 10 which follows. Exposure was conducted with the dental lamp at a distance of 1 inch from the sample to provide an intensity of about 0.26 W/cm 2 . Molar ratios are fluorone:onium salt:amine.
- EXAMPLE 37 was repeated using DIBF in place of TIHF in the concentration and molar ratios shown in the following Table 11.
- This example illustrates the preparation of an onium salt complex from TIHF and diphenyliodonium chloride.
- TIHF 7.15 g TIHF was washed with diluted HCl solution and subsequently washed with a large quantity of H 2 O to make sure all the dye is in the acidic form.
- the TIHF was dissolved in 65 Ml DMF.
- Fresh Ag 2 O was prepared by mixing approximately equimolar aqueous solutions of AgNO 3 and NaOH together, the precipitated black Ag 2 O was filtered and washed with large quantity of distilled water.
- 2.2 g moist Ag 2 O and 3.5 g diphenyliodonium chloride were mixed together in a glass mortar. The reagents were thoroughly ground together until no trace of iodonium compound could be discerned.
- the black slurry was then washed into a sintered glass filter and the precipitate washed with H 2 O until 35 ml filtrate was obtained.
- the filtrate was filtered again until the solution of diphenyliodonium hydroxide was transparent.
- the DMF solution of TIHF and the aqueous solution of diphenyliodonium hydroxide was mixed together and the DMF/H 2 O solvent was vacuum distilled off until only a small volume remained.
- the dye onium complex salt was precipitated from the solution by adding a large quantity of H 2 O, and dried in an oven at 60° C. overnight. The yield is 80%.
- the photohardenable compositions of the present invention can be coated upon a support in a conventional manner and used in making a photoresist or in photolithography to form an oleophilic polymer image.
- Development of photohardenable compositions in accordance with the invention is conducted in an otherwise known or conventional manner, e.g., a solvent for the unpolymerized monomer may be used to remove the photohardenable composition in the unexposed areas.
- compositions of the invention can also be encapsulated as described in U.S. Pat. Nos. 4,399,209 and 4,440,846 and used to control the release of an image-forming agent.
- the latter processes typically involve image-wise exposing the photosensitive layer to actinic radiation and subjecting the layer of microcapsules to a uniform rupturing force such as pressure.
- the photohardenable composition of the invention are also advantageous for use in the three dimensional modeling process taught in U.S. Pat. No. 4,575,330 to Hull. Due to the thicker depth of cure that is possible, models may be prepared in larger cross-sectional increments. This should reduce the total time required for the model building process. Another advantage which the claimed compounds bring to three dimensional modeling is higher green strength.
- fluorones in accordance with the invention absorb at about 360 to 635 nm. It is anticipated that sensitivity can be extended to longer wavelengths by substituting electron donating groups for R. Depending upon the extinction coefficient, compositions and photosensitive materials in accordance with the invention can be exposed to any source which emits in this range and particularly an He/Cd laser, or mercury arc lamps.
- the invention also includes the use of fluorones in dosimeters and more particularly in dosimeters useful in wave length sensitive laser dosimeters.
Abstract
The present invention relates to a novel class of compounds which absorb light at wavelengths greater than 350 nm and are useful as fluorescers or as photoinitiators. The present invention provides compounds of the formulas (I) and (II) and their equivalents (the nomenclature of the compounds used herein is based on the numbering of positions as shown in formula (I)): ##STR1## where: when W is ═O, W1 is hydrogen or --OR9 and when W is ═NR+ 2, W is hydrogen or NR2 +2, A is hydrogen, alkenyl, alkyl or an election withdrawing group, and the remaining groups are as defined in the disclosure.
Description
This application is a combined continuation-in-part of U.S. application Ser. No. 07/881,048 filed May 11, 1992, now abandoned and Ser. No. 07/772,103 filed Oct. 7, 1991, now abandoned which in turn is a continuation-in-part of Ser. No. 07/756,611 filed Sep. 9, 1991 now abandoned, which in turn is a continuation-in-part of Ser. No. 07/702,886 filed May 20, 1991 now abandoned.
The present invention relates to a novel class of compounds which absorb light at wavelengths greater than 350 nm and are useful as fluorescers or as photoinitiators. The present invention provides compounds of the formulas (I) and (II) and their equivalents (the nomenclature of the compounds used herein is based on the numbering of positions as shown in formula (I)): ##STR2## where R1, R2, R5 and R6 are the same or different and represent a hydrogen atom or a halogen atom and R1 and R2 may combine to form a ring; R3 and R4 are the same or different and represent a hydrogen atom, a halogen atom, a benzoyl group, a group of the formula --L(CH2)n R8 where n is 1 to 8, R8 is hydrogen, hydroxy, amino, dialkylamino, --COR16, or --COOR14 where R16 is hydrogen, chlorine, COCl, C1-C8 alkyl, NR2, aryl, and R14 is hydrogen, C1-C8 alkyl, aryl, COR, 2,4-dinitrophenyl, N-imido or NR2 and L is a direct bond or >C═O; W is ═O or ═N+ 2 where R is hydrogen or lower alkyl, when W is ═O, W1 is hydrogen or --OR9 where R9 is hydrogen, C1-C8 alkyl, acyl or a group of the formula--(CH2)n 10 where n is 1 to 8 and R10 is amino, dialkylamino, hydroxy, acryloyl or methacryloyl and when W is ═NR+ 2, W1 is hydrogen or --NR2 ; Y is oxygen, sulfur, selenium, tellurium, >C═O, or N--R13 where R13 is 4-methylphenyl, A is hydrogen, alkenyl, alkyl, or an electron withdrawing group (EWG); provided that when R1 -R6 are all hydrogen, A is not hydrogen or methyl.
A further embodiment of the invention is ionically bonded complexes of the aforesaid compounds in which W is O and W1 is --OR9 and one or two iodonium cations. When W1 is O- as in TIHF below, the compounds are believed to form ionic complexes with iodonium cations at the 3- and 6-positions in a ratio of 2 cations per complex. When W1 is not O- as in an alkoxy group as in DIBF below, the compounds are believed to form ionic complexes with an iodonium cation at the 6-position in a ratio of 1 cation per complex.
Depending upon structure and substitution, the compounds of the invention absorb visible light or infrared radiation and fluoresce or act as electron donors or electron acceptors in photoinitation. As contrasted with conventional fluorescein dyes, the addition of a strong EWG at the 9 position corresponding to A extends the wavelength of maximum absorption approximately 100 nm to longer wavelengths.
In accordance with some of preferred embodiments of the invention, the compounds of the invention more particularly include fluorone and pyronin Y derivatives of the formula the (III) and (IV): ##STR3## where A is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, dichlorotriazinylamino, and electron withdrawing groups (EWG) which are stronger electron withdrawing groups than a phenyl group or a halogen-substituted or a carboxyl-substituted phenyl group; Y1 is oxygen, sulfur or >NR13 where R13 is 4-methylphenyl; R, and R1 -R4 are defined as above; Z is a counter ion and W2 is hydrogen or --OR9 and R9 is defined as above.
The compounds of the invention can be more specifically represented by the formula (V): ##STR4## where R1 -R4 may be the same or different and are defined as above; EWG is an electron withdrawing group selected from the group consisting of COOR11, COR12, C(O)OCOR11, CONR2, CN NO2, NCS, NCO SO2 R12, SO3 R11, SO2 NR2, CX3 2 ; R11 is hydrogen, alkyl, aryl, or aralkyl; R12 is hydrogen, alkyl, aryl, or aralkyl, X2 can be the same or different and is a halogen atom; and W and W' are selected from the group consisting respectively of ═O and O-- and ═NR2 + and --NR2 where R is defined as above. When the compounds are fluorescers one of A, R3 and R4 may be a linking group (for example R, R11 or R12 as defined above may be, N-imido such as N-succinimido and N-maleimido, or NR2). When R11 is N-imido or --NR2 the compounds are esters of N-hydroxyimides such as N-hydroxysuccinimides or N-hydroxyamines.
In the photoinitiators of the invention at least one and preferably at least two of R1 -R6 is a halogen atom and more particularly an iodine or bromine atom. A is hydrogen or cyano in a particularly preferred class of photoinitiators. For use in photoinitiation W1 is preferably butoxy or octyloxy. When R10 is an acrylolyl or methacryloyl group, a polymerizable initiator is provided.
In the fluroescers of the invention R1 -R6 cannot be bromine or iodine and R9 must be hydrogen when W1 is --OR9. To exhibit fluorescence, the compounds must be ionized. In one embodiment of the invention, R4 may be a moiety which produces intramolecular ionization of the compound at W/W1. For intramolecular ionization at least one of R3 -R4 will have a basic functional group when W/W1 is O/O- and have an acid functional group when W/W1 is NR2 +/NR2. Examples of such moieties are acetyl and amino groups.
In one embodiment of the invention the compounds may be linked to an antibody or a ligand analog for use in immunoassays. For use in immunoassays, at least one of A, R3 or R4 includes a functional group (hereafter a "coupling group") such as an amino group, a carboxyl group, a tert-butoxycarbonyl group (TBOC), a sulfinyl group, a sulfonyl group, an isocyanato group, an isothiocyanato group, a halogen atom, an N-hydroxysuccinimide ester or a N-hydroxy maleimide ester, etc. which enables the compound to be coupled with a ligand analog, an antibody or similar substrate.
In another embodiment the compounds may be substituted with one or more oleophilic moieties which make the compounds soluble in oil and useful as fluorescent dyes for oil leak detection or as oil soluble photoinitiators. The oil solubility of the compounds can be tailored to a particular application by the addition of longer chain, e.g., C4-C8 groups at one or more of R3, R4 and W1. For example, the compounds may be substituted at R3, R4 and W1 by alkyl, alkylcarbonyl, carboxyalkyl or alkylcarboxyalkyl groups. For use as a fluorescent dye in oil leak detection R3 and/or R4 may be substituted by t-butyl or longer chain substituted or unsubstituted alkyl. The addition of alkyl groups at the 2 and 7 positions extends absorption in the red at least an additional 20 nm, increases the fluorescence quantum yield, and decreases the bleaching rate.
The invention also provides tracers useful in immunoassays of the formula (VI): ##STR5## where Y2 is a linking group and A' is a ligand-analog as defined in U.S. Pat. No. 4,585,862 or an antibody, and EWG is defined as above. U.S. Pat. No. 4,585,862 is incorporated herein by reference. In one embodiment, the linking group Y2 is the divalent analog of one of the aforesaid functional groups defined for EWG, R3 or R4. Particularly useful linking groups include an oxalyl group, a sulfonyl group, a sulfinyl group, a hydroxyimido ester group, a group of the formula --(CH2)n --R15 where R15 is oxalyl chloride, carbonyl chloride (COCl), nitrobenzoate ester (e.g., a 2,4-dinitrophenyloxycarbonyl), N-hydroxyimido groups, TBOC esters, or a carboamidosulfonyl or a carboamidosulfinyl group. In another embodiment the antibody or ligand-analog may be linked to the tricyclic nucleus via the moiety X3 in formula (VII) below. In still another embodiment linkage may be via the A moiety at the 9-position. One compound which may be useful in immunoassays is substituted by hydrogen at the 9-position and cyano, isocyanato or isothiocyanato at one of the 2, 4, 5 and 7 positions.
Representative examples of alkyl groups referenced with respect to the compounds of formula (I)-(VI) above are straight chain, branched chain and cyclic alkyl groups having 1 to 10 carbon atoms.
Representative examples of aryl groups include phenyl groups which may be unsubstituted or substituted by alkyl, (CH2)p COOR11, (CH2)p X2, (CH2)p NR2, where R, R11 and X2 are defined as above and p is 0 to 6.
Representative examples of aralkyl groups include aralkyl groups containing 7 to 20 carbon atoms such as benzyl, phenethyl, etc.
Representative examples of alkaryl groups include alkaryl groups containing 7 to 20 carbon atoms such as phenyl substituted at the ortho or para position by a straight chain or branched chain alkyl group having 1 to 6 carbon atoms.
Representative examples of alkenyl groups include alkenyl groups having 2 to 10 carbon atoms such as vinyl, allyl, 1-propenyl, 1-butenyl and 1,3-butadienyl.
Representative examples of alkynyl groups include alkynyl groups having up to 10 carbon atoms such as 1-propynyl, 1-butynyl, etc.
Representative examples of acyl groups are groups of the formula --OCR where R is alkyl or p-aryl such as methyl or phenyl.
Representative examples of the halogen atoms include fluorine, chlorine, bromine and iodine and, more particularly, fluorine or chlorine in the case of fluorescers and bromine or iodine in the case of photoinitiators.
Representative examples of electron withdrawing groups include COOR11, COR12, C(O)OCOR11, CONR2, CN, NO2, NCS, NCO, SO2 R12, SO3 R11, SO2 NR2, CX32 where X2, R11 and R12 are defined below.
The term "N-imido" as used herein refers to groups such as N-maleimido and N-succinimido.
When R1 and R2 combine to form a ring, the compounds in accordance with the invention can be represented by the formula VII. ##STR6## where EWG, R3 and R4 are defined as above, n is 2 or 3, and X3 is >NH, >NR13, O, S, PR17, CHR17 where R17 has the same definition as R3 -R4 but can be the same as or different than R3 -R4 and may additionally represent dichlorotriazinyl.
Representative examples of the counter ion represented by Z include chloride, bromide, iodide, perchlorate when Z is an anion and monovalent ions such as K+, Na+, ammonium, phosphonium, etc. when Z is a cation. When W/W' is O/O-, Z may be hydrogen.
Representative examples of photoinitiators in accordance with the invention include:
1. 5,7-diiodo-3-methoxy-6-fluorone (DIMF)
2. 5,7-diiodo-3-ethoxy-6-fluorone (DIEF)
3. 5,7-diiodo-3-butoxy-6-fluorone (DIBF)
4. 5,7-diiodo-3-octoxy-6-fluorone (DIOF)
4a. 4,5-diiodo-3-hydroxy-6-fluorone
5. 9-cyano- 5,7-diiodo-3-methoxy-6-fluorone (CDIMF)
6. 9-cyano- 5,7-diiodo-3-ethoxy-6-fluorone (CDIEF)
7. 9-cyano- 5,7-diiodo-3-butoxy-6-fluoorone (CDIBF)
8. 9-cyano-5,7-diiodo-3-octoxy-6-fluorone (CDIOF)
9. 3-hydroxy-2,4,5,7-tetraiodo-6-fluorone (TIHF)
10. 3-hydroxy-2,4,5,7-tetrabromo-6-fluorone (TBHF)
11. 3-hydroxy-2,4,5,7-tetrachloro-6-fluorone (TCHF)
12. 3-hydroxy-2,4,5,7-tetrafluoro-6-fluorone (TFHF)
13. 9-cyano-3-hydroxy-2,4,5,7-tetraiodo-6-fluorone (TIHCF)
14. 9-cyano-3-hydroxy-2,4,5,7-tetrabromo-6-fluorone (TBHCF)
15. 9-cyano-3-hydroxy-2,4,5,7-tetrachloro-6-fluorone (TCHCF)
16. 9-cyano-3-hydroxy-2,4,5,7-tetrafluoro-6-fluorone (TFHCF)
17. 3-hydroxy-4,5,7-triiodo-2octanoyl-6-fluorone
18. 9-cyano-3-hydroxy-4,5,7-triiodo-2-octanoyl-6-fluorone
19. 3-hydroxy-4,5,7-triiodo-2-octanoyl-6-fluorone
20. 9-cyano-3-hydroxy-4,5,7-triiodo-2-octyl-6-fluorone
21. 3-hydroxy-2,4,5,7-tetraiodo-6-thiafluorone
22. 3-hydroxy-4,5,7-triiodo-2-pentanoyl-6-fluorone
23. 9-cyano-3-hydroxy-4,5,7-triiodo-2-pentanoyl-6-fluorone
24. 3-hydroxy-4,5,7-triiodo-2-pentyl-6-fluorone
25. 9-cyano-3-hydroxy-4,5,7-triiodo-2-pentyl-6-fluorone
26. 2,7-di-t-butyl-4,5-diiodo-3-hydroxy-6-fluorone
27. 9-cyano-2,7-di-t-butyl-4,5-diiodo-3-hydroxy-6-fluorone
28. 7-benzoyl-2,4,5-triiodo-3-hydroxy-6-fluorone
Representative examples of fluorescers in accordance with the invention include:
29. 3-hydroxy-6-thiafluorone
30. 2,7-di-t-butyl-3-hydroxy-6-fluorone
31. 9-cyano-2,7-di-t-butyl-3-hydroxy-6-fluorone
32. 2,7-di-t-butyl-4,5-carboxymethyl-3-hydroxy-6-fluorone
33. 9-cyano-2,7-di-t-butyl-4,5-carboxymethyl-3-hydroxy-6-fluorone
34. 9-trifluoromethyl-2,7-di-t-butyl-3-hydroxy-6-fluorone
35. 9-trifluoromethyl-2,7-di-t-butyl-4,5-carboxymethyl-3-hydroxy-6-fluorone
36. 9-trifluoromethyl-3-hydroxy-6-fluorone
37. 3-hydroxy-7-pentanoic acid-6-fluorone
37a. 3-hydroxy-7-butyric acid-6-fluorone
37b. 9-cyano-3-hydroxy-7-butyric acid-6-fluorone
38. 9-cyano-3-hydroxy-7-pentanoic acid-6-fluorone
39. 2,7-dicitronellic acid-3-hydroxy-6-fluorone
40. 9-cyano-2,7-dicitronellicacid-3-hydroxy-6-fluorone
41. 9-cyanopyronin-Y
42. 2,7-di-t-butylpyronin-Y
43. 9-cyano-2,7-di-t-butylpyronin-Y
44. Compound I. ##STR7##
Compounds 37, 37a, 37b, 39 and 40 are 7-carboxy derivatives which can be converted to the N-hydroxysuccinimide ester, the N-maleimide, the t-BOC ester or the acid chloride to introduce linking groups therein.
In accordance with the invention, compounds are provided which absorb at wavelengths greater than 450 nm and preferably greater than 550 nm. In most compounds, these longer wavelengths of maximum absorption are believed to be attributable to the presence of a strong EWG at the 9-position. Preferred among these are morieties which extend resonance conjugation such as cyano. This effect is illustrated in the following table for compounds of the formula (I) wherein the substituents are as defined as in the following Table 1:
TABLE 1 __________________________________________________________________________ Y.sup.1 W/W' A R.sup.1 R.sup.2 R.sup.3 R.sup.4 λmax in ETOH ε __________________________________________________________________________ O O/O.sup.- H H H H H 504 24700 O O/O.sup.- CN H H H H 594, 548 50300, 24700 O O/O.sup.- H Br Br Br Br 530 39300 O O/O.sup.- CN Br Br Br Br 626, 576 51400, 24500 O O/O.sup.- H I I I I 536 91200 O O/O.sup.- CN I I I I 638, 586 80000, 35000 O O/O.sup.- H I I I I 520 86000 O O/O.sup.- CN I I I I 618, 570 30500, 16600 O O/O.sup.- H H H t-But t-Bu 518 101000 O O/O.sup.- CN H H t-But t-Bu 614, 564 47400, 23200 O O/O.sup.- H I I t-But t-Bu 532 90800 O O/O.sup.- CN I I t-But t-Bu 636, 582 68300, 33600 O O/OMe H I I I H 470 23,500 O O/OEt H I H I H 470 21,100 O O/OBu H I H I H 470 30,200 O O/OOc H I H I H 470 31,600 O O/OBu CN I H I H 600 (down)broad O O/O.sup.- H H H H (CH.sub.2).sub.3 COOEt 510 -- O O/O.sup.- H H H H (CH.sub.2).sub.3 COOK -- -- O O/O.sup.- H H H H (CH.sub.2).sub.3 COOH -- -- O O/O.sup.- CN H H H (CH.sub.2).sub.3 COOH 596 74,000 O O/O.sup.- H H H H (CH.sub.2).sub.4 COOH -- -- O O/O.sup.- CN H H H (CH.sub.2).sub.4 COOH -- -- O O/O.sup.- H H H H (CH.sub.2).sub.3 COOH 512 O O/O.sup.- H I H I CO(CH.sub.2).sub.6 CH.sub.3 538 84,800 O O/O.sup.- CN I H I CO(CH.sub.2).sub.6 CH.sub.3 636 17,000 O O/O.sup.- H I H I (CH.sub.2).sub.7 CH.sub.3 534 92,600 O O/O.sup.- CN I H I (CH.sub.2).sub.7 CH.sub.3 630 40,000 O O/O.sup.- (CH.sub.2).sub.6 OCOCH═CH.sub.2 H I H I H 472 O O/O.sup.- H H H H (CH.sub.2).sub.3 COONHS ester* O O/O.sup.- CN H H H (CH.sub.2).sub.4 COONHS ester NφCH.sub.3 NH.sub.2 /NH.sub.2 .sup.+ H H H H H 472 NφCH.sub.3 NH.sub.2 /NH.sub.2 .sup.+ H I I I I 472 S O/O.sup.- H H H H H 524 S O/O.sup.- CN H H H H 610 S O/O.sup.- H I I I I -- __________________________________________________________________________ *NHS = Nhydroxysuccinimide
As the table indicates, in accordance with certain embodiments, the compounds absorb strongly in the range of 650-700 nm.
Certain more specific embodiments of the invention are fluorescers of the formula (IV) where R is methyl and more particularly, R is methyl and A is hydrogen or cyano; photoinitators of the formula (III) where A is hydrogen or cyano and two or more of R1 -R4 are iodo or bromo and preferably iodo and still more preferably compounds of the formula (III) in which R1 and R3 are iodo, or R1 and R2 are iodo, or R1, R2 and R3 are iodo, or R1, R2, R3 and R4 are iodo; fluorescers of the formula (III) where R1 , R2 and R3 are hydrogen, A is hydrogen or cyano, and R4 is substituted to enhance solubility or with a linking group.
The synthesis of fluorones in accordance with the present invention is illustrated in Scheme 1 below and by the following Synthesis Examples.
2,2',4,4'-Tetrahydroxybenzophenone (2.5 g, 10.15 mmol.) was heated in 20 ml of water at 195°-200° C. for 4 hours (Aldrich pressure tube). After cooling, the crude product was filtered off and mixed with 25 ml of water. The resulting suspension was refluxed for 25 min. and filtered at about 60° C. Pure product 3,6-dihydroxyxanthone 2.15 g was obtained in 90.4% yield. It did not melt below 330° C. HNMR (DMSO): 10.780 (s,2H), 7.983 (d,2H,J=8.6 Hz), 6,822 (m,4H). MS: 228,220, 1717, 115, 100, 69, 63.
To a suspension of 3,6-dihydroxyxanthone (46 g, 201 mmol.) obtained as in Example 1 in 1.6 L of THF was added over 1 hr 800 ml of borane-tetrahydrofuran complex (1.0M in THF, caution very vigorous raction at beginning). This mixture was stirred overnight under argon at room temperature to give a clear yellow solution. The excess diborane was decomposed by careful addition of water followed by 1N HCl to give a clear yellow solution. The tetrahydrofuran was removed by rotary evaporation and the resulting solid filtered, washed with water and redissolved in 10% NaOH. This solution was filtered, cooled and reprecipitated with slow addition of HCl to give a yellow solid which was filtered, washed with water and dried under vacuum to give 40.14 g (93%, mp 207-208) of 3,6-Dihydroxyxanthane. H1 NMR (DMSO): 9.41 (s, 2H); 6.97 (d, 2H, J=8.4 Hz), 6.4 (dd, 2H, J=8.4, 2.4 Hz), 6.39 (d, 2H, J=2.4 Hz), 3,765 (s, 2H).
Iodic acid (16.4 g, 93 mmol) dissolved in a minimum amount of water (app. 1 ml per gram) was added dropwise over 20 min. to a solution of 10 g (46.7 mmol) of 3,6-dihydroxyxanthane and 29.8 g (118 mmol) of iodine in 1 L of absolute ethanol. This mixture was stirred over two hours during which the dark brown solution slowly turned a red orange as the solid initiator precipitated. The mixture was then warmed for an hour at 60° C. After cooling, the mixture was filtered, washed with water and ethanol and the crude solid tritiated with absolute ethanol and refiltered to give, after drying under vacuum, 29 g (87%) of a red solid (λ=536 nm in ethanol) H1 NMR (DMSO) 8.31 (s, 2H), 8.07 (S, 1H).
To a solution of 3,6-dihydroxyxanthane (2.14 g 10 mmol) obtained as in example 2 in 60 ml of ethanol at 25° C. was added DDQ (2.78 g, 12 mmol). The reaction mixture was stirred for 8 hours at room temperature. The yellow precipitate was filtered off and washed with ethanol. 3-Hydroxy-6-fluorone (1.9 g) was obtained in 90% yield. NMR (DMSO): 8.203 (s, 1H), 7,589 (d, 2H, J=8.6 Hz), 6.659 (d, 2H, J=9.2 Hz), 6.478 (s, 2H). λmax=500 nm (MeOH).
To a solution of 3,6-dihydroxyxanthane (4.28 g 20 mmol) in 150 ml of ethanol was added sodium hydroxide solution (4.8 g, 120 mmol in 10 ml of H2 O). The solution was cooled to 0° C. then Br2 (22.4 g, 140 mmol) was slowly added. After addition, the reaction mixture was stirred for 8 hrs. at room temperature. Precipitate was filtered off and washed with ethanol. 2,4,5,7-tetrabromo-3-hydroxy-6-fluorone (9.16 g 90.8%) was obtained. NMR (DMSO) 8.309 (s, 1H0, 8.244 (s, 2H), λmax=526 nm (methanol).
In Table 2 below, the properties of the foregoing initiators are shown:
TABLE 2 __________________________________________________________________________ Compound λmax.sup.a λf.sup.b φf pKa Eox Ered λphos __________________________________________________________________________ HF 500, 504, 490 506, 513 .95.sup.c 5.97 1.34 .99 -- TBHF 526, 530, 516 539 .52 3.28 1.099 .95 -- TIHF 532, 536, 526 544, 549 .13 4.08 1.04 .95 676 __________________________________________________________________________
Entries in the table are in the solvents according to the following order.
a. MeOH, EtOH, 10% MeOH/90% water
b. MeOH, EtOH
c. 10-7 M
Potassium cyanide (1.175 g, 18.0 mmol) was added to a solution of TIHF (10.74 g 15.0 mmol) in 100 ml of DMF. The reaction was monitored by its visible spectrum until all of the TIHF was consumed. The solvent was removed with a vacuum pump at room temperature and the residue was treated with 1:1 hexane/dichloromethane. The precipitate was filtered, dried and treated with 18% HCl then washed with water. 2,4,5,7-tetraiodo-9-cyano-3-hydroxy-6-fluorone (10.60 g) was obtained (975). HNMR (DMSO): 8.006 (2H,s) max (EtOH=638 nm).
7.0 g (30.7 mmol) of 3,6-dihydroxyxanthone is dissolved in aq. NAOH (2.5 g(62.5 mmol) in 200 mls H2 O). 3.2 mls (33.6 mmol) of dimethylsulfate is added dropwise with stirring, and solid forms immediately upon completion. Stirred further 1 hour and heated to reflux for 15 minutes. Additional base is added to insure complete solubility of phenols. The solution is acidified with HCl, and filtration yields a mixture of staring material and the target compound. Solid is heated to reflux in about 200 mls ethanol for 15 minutes to dissolve starting material, and solid is filtered out, washing with ethanol and water. This may have to be repeated several times to obtain pure compound in about 50% yield; mp=303-306-C.NMR (200 MHZ in d-DMSO) s 3.89 (3H,s), 6.82 (1H,d,J=2.24 Hz), 6.87 (1H,m), 6.99 (1H,dd,J=8.78 Hz, 2.20 Hz),, 7.09 (1H,d,J=2.26Hz), 7.99 (1H,d,J=8.52 Hz), 8.03 (1H,d,J=8.78Hz).
To a solution of 4.0 g (16.5 mmol) of 6-hydroxy-3-methooxyxanthone in 150 mls of anhydrous THF under nitrogen is added with stirring 41 mls (41 mmol) of 1M BH3 in THF. Reaction mixture is stirred overnight at room temperature. Solvent is stripped and flask washed out with aq. NaOH, dissolving product completely. After filtration to remove impurities, the solution is acidified, filtered and washed with water to yield 3.73 g (99%) of yellow product xanthane. NMR (200 MHz in d-DMSO) s 3.72 (3H,s), 3.82 (2H,s), 6.46 (2H,M), 6.63 (2H,m), 7.00 (1H,d,J=8.12Hz), 7.10 (1H,d,J=9.46 Hz). MS: 227,212,197,184,128.
The synthesis of 5,7-diiodo-3-alkoxy-6-fluorones and their 9-cyano derivatives is shown in the following Synthesis Examples 9-17.
To a solution of 0.228 g (1 mmol) of 6-hydroxy-3-methoxyxanthane and 0.508 g (4 mmol) of iodine in 20 mls of ethanol, 0.211 g (1.2 mmol) of iodic acid in minimum water is added dropwise with stirring. Precipitate forms immediately, and reaction is stirred 1 hour at room temperature when warmed to 50 - C. for 15 minutes. Filtration and washing with ethanol and water yields 0.44 g (92%) of orange 5,7-diiodo-3-methoxy-6-fluorone. NMR (200 MHz in d-DMSO) s 3.96 (3H,s), 7.10 (1H,dd,J=8.72 Hz,2.38 Hz), 7.19 (1H,d,J-2.38), 7.86 (1H,d,J=8.74Hz), 8.35 (1H,s), 8.46 (1H,s). MS: 478,450,351,323,196,181,125.
3,6-Dihydroxy xanthone (1,60.7 mmol) was dissolved into hot basic water (Na2 CO3 240 mmol in 600 ml water). After the 3,6-dihydroxy xanthone was completely dissolved, the temperature was controlled to 70° C. Isopropyl alcohol (10 ml) was added to the reaction mixture and butyl bromide (180 mmol) was added dropwise. The reaction mixture was stirred rigorously for 72 hours. A white precipitate appeared which was then filtered and washed with water. There was almost no disubstituted compound in the product. This precipitate was dissolved in 3% NaOH, filtered and finally reprecipitated with HCl yielding 90% of 3-butoxy-6-hydroxy xanthone.
Continuous efforts have been made to improve the reaction conditions for a synthesis of 3-butoxy-6-hydroxy xanthone. The results of attempts to increase the yield by changing various reaction conditions in Example 10 are shown in Table 3.
TABLE 3 ______________________________________ Run-1 Run-2 Run-3 Run-4 Ref. ______________________________________ Concentration of 6.9 5 5 5 2.3 Xanthone (wt %) Water/i-PrOH (volume) 60/1 9/1 60/1 30/1 60/1 Temperature (°C.) 70 80 70 70 70 Reaction time 72 72 100 72 72 (hours) Monobutyl 38 23 73 81 90 xanthone (%) Dibutyl xanthone trace 65 trace trace trace (%) Starting 60 11 11 22 10 material (%) ______________________________________
The increase of i-PrOH ratio and the temperature (Run-2) drastically boosted the yield of side product, dibutyl xanthone. Run-3 showed that a slight reduction of the concentration could improve the yield of monobutyl xanthone, but it is still not a satisfying yield even with a prolonged reaction time. An increase of i-PrOH (Run-4) could improve the yield of monobutyl xanthone keeping the side product only at a trace amount.
3,6-Dihydroxy xanthone (1,20 mmol) was dissolved in hot mixture of basic water (80 mmol of Na2 CO3 in 100 ml of water) and 50 ml of methanol. After the compound was completely dissolved, a methanol solution of octyl bromide (40 mmol in 50 ml of methanol) was added dropwise and the reaction mixture was stirred rigorously for 120 hours at refluxing temperature. The reaction mixture was cooled to room temperature giving a precipitate. This white precipitate was then filtered, washed with water, and washed with hot hexane to remove the disubstituted side product. 3-Octoxy-6-hydroxy xanthone was obtained in 30% yield. 1 HNMR (DMSO): d11.0(1H,s), 8.05 (1H,d,J=6.0 Hz), 8.02 (1H,d,J=5.8 Hz), 7.08 (1H,s), 7.00 (1H,d,J=8.8 Hz), 6.89 (1H,d,J=8.8 Hz), 6.85 (1H,s), 4.43 (2H,t,J=6.2 Hz), 1.8(2H,M), 1.3 (10H,m), 0.9 (3H,t).
Using the procedure of Synthesis Example 12 and substituting butyl bromide, the title compound was prepared.
3-Octoxy-6-hydroxy xanthone (3 mmol) was dissolved in 50 ml of THF. BH3 THF (10 mmol ) was added at room temperature and stirred overnight. Dilute HCl (ca. 1N) was added until the bubbling ceased. An additional 3 ml of water was added and the THF was removed. The remaining precipitate was filtered, washed with water and dried yielding 99.3% of 3-octoxy-6-hydroxy xanthane 3(b). 1 H NMR (DMSO): 9.49 (1H,s), 7.10 (1Hd,J=7.9 Hz), 7.01 (1H,d,J=8.3 Hz), 6.64 (1H,d,J=7.4 Hz), 6.60 (1H,s), 6.49 (1H,d,J=8.5 Hz), 6.43 (1H,s), 3.94 (2H,t,J=6.0 Hz), 3.85 (2H,s), 1.7(2H,m), 1.3 (10H,m), 0.9 (3H,t).
Using the procedure of Synthesis Example 13, and substituting 3-butoxy-6-hydroxy xanthane, the title compound was prepared.
3-Butoxy-6-hydroxy xanthane (100 mmol) and I2 (100 mmol) were dissolved in 200 ml of methanol. After HIO3 aqueous solution (100 mmol dissolved in 20 ml of H2 O) was dropped slowly into the reaction mixture at 50° C., it was stirred 3 hours. The resulting precipitate was filtered and washed with methanol and dried in a vacuum oven. The yield was 96%.
3-Octoxy-6-hydroxy xanthane (2 mmol) and iodine (4 mmol) were dissolved in 30 ml of ethanol. An aqueous solution of iodic acid (4 mmol in 1 ml H2 O) was poured into this mixture slowly at room temperature. The reaction mixture was stirred for 1 hour at 60° C., then cooled to 0° C. The resulting orange precipitate was filtered, washed with ethanol to remove iodine, washed with water to remove iodic acid and then washed with ethanol again. The yield of 3,5-diiodo-7-octoxy fluorone (DIOF) was 83.6%. 1 H NMR (CDCl3): 8.12 (1H,s), 7.72 (1H,s), 7.59 (1H,d,J=8.7 Hz), 7.05 (1H,s), 6.99 (1H,d,J=8.8 Hz), 4.14 (2H,t,J=6.4 Hz), 1.9 (2H,m), 1.4 (10H,m), 0.9 (3H,t).
The reaction mixture of DIBF (4 g, 2 mmol) and KCN (6 mmol) in dry DMF (10 ml) was stirred at room temperature. After stirring for 2 hours, the reaction mixture turned deep green. Formic acid (1 ml) was added and the mixture was stirred for 3 more hours. The reaction mixture turned red-purple. Then it was poured into water, extracted with dichloromethane and washed with water. The dichloromethane was removed under reduced pressure to leave the 9-cyano DIBF (DICGF, 5a). DICBF was then purified by using column chromotography. The yield was 54%. 1 HNMR (CDCl3): 8.48 ppm (1H,s), 7.83 (1H,d,,J=9.5 Hz), 7.05-7.09 (1H,m), 7.04 (1H,s), 4.16 (1H,t,J=6.5 Hz), 1.8-1.9 (1H,m), 1.5-1.6 (4H,m), 1.02 (3H,t,J=7.3 Hz).
3-hydroxy-4,5,7 triiodo-2-octanoyl fluorone and its 9-cyano derivative can be prepared as in Synthesis Examples 18-23.
3,6-Dihydroxy xanthone (1,30 mmol) was dissolved in basic water (NaOH 100 mmol in 200 ml of water). Me2 SO4 was added dropwise and the mixture was stirred for 3 hours at room temperature and 1 hour at 80° C. The resulting precipitate was filtered, washed with NaOH aqueous solution, and then with water yielding 61% of 3,6-dimethoxy xanthone. 1 HNMR (CDCl3): 8.25 ppm (2H,d,J=8.8 Hz), 6.94 (2H,dd,J1=8.9 Hz,J2=2.4 Hz), 6.87 (2H,d,J=2.2 Hz), 3.94 (6H,s).
3,6-Dimethoxy xanthone (20 mmol) was dissolved in THF. BH3 THF was added dropwise at room temperature and the reaction mixture was stirred overnight. HCl (1N) was added until bubbling ceased. 20 ml of water was added and the THF was removed under reduced pressure. The residual solid was filtered, washed with water to give a quantitative amount of 3,6-dimethoxy xanthane. 1 HNMR (CDCl3): 7.05 ppm (1H,d,J=9.1 Hz), 6.60-6.64 (1H,m), 6.59(1H,s), 3.91(2H,s), 3.80(6H,s).
3,6-dimethoxy xanthane (8 mmol) and octanoyl chloride (8 mmol) were dissolved in anhydrous dichlormethane and the solution was cooled with dry ice in ethanol. Aluminum chloride (10 mmol) was added to the solution and the temperature was gradually elevated to room temperature. After stirring for 2 hours at room temperature, the reaction mixture was cooled again with dry ice in ethanol. HCl (1N, 40 ml) was added and the organic compounds were extracted with dichloromethane and washed with water several times. The dichloromethane was removed under reduced pressure. The residual material was almost pure mono-substituted (2 position) compound. The mixture was dissolved in hot hexane and allowed to cool gradually, to give the recrystallized 2-octanoyl-3,6-dimethoxy xanthane in 70% yield. 1 HNMR (CDCl3): 7.64 ppm(1H,s), 7.09(1H,d,J=8.3 Hz), 6.6-6.7 (1H,M), 6.63 (2H,s), 3.95 (2H,s), 3.92 (3H,s), 3.82 (3H,s), 2.96 (2H,t,J=7.0 Hz), 1.6-1.8 (2H,m), 1.2-1.4 (8H,m)., 0.90 (3H,t).
2-Octanoyl-3,6-dimethoxy xanthane (8, 1 mmol) and 5 ml of ethanethiol were dissolved in 20 ml of anhydrous dichloromethane. The mixture was cooled to -15° C. in salt/ice bath. After aluminum chloride (5 mmol) was added, the reaction mixture was heated to room temperature and stirred overnight. The reaction mixture was poured into a mixture of 10 g of ice and 5 ml of conc. HCl to obtain a precipitate. The precipitate was dissolved in NaOH aqueous solution and reprecipitated in dilute HCl. The precipitate was finally filtered, washed with water to yield 50% of 2-octanoyl-3,6-dihydroxy xanthane. 1 HNMR (DMSO): 12.25 ppm (1H,s), ,9.58 (1H,s), 7.87 (1H,s), 7.06 (1H,d,J=8.3 Hz), 6.58 (2H,s), 6.50 (1H,d,J=8.5 Hz), 3.89 (2H,s), 3.03 (2H,t,J=7.1 Hz), 1.5-1.7 (2H,m), 1.2-1.4 (8H,m), 0.87 (3H,t).
2-Octanoyl-3,6-dihydroxy xanthane (9, 0.3 mmol) and I2 (0.6 mmol) were dissolved in 3 ml of ethanol. An aqueous solution of HIO3 (0.6 mmol in 0.3 ml of water) was added and the mixture was stirred for 1 hour at room temperature and 3 hours at reflux temperature. The resulting red solid was filtered and washed with ethanol. The yield of 3-hydroxy-2-octanoyl-4,5,7-triiodo-6-fluorone was 67%. The compound showed poor solubility in DMSO and almost no solubility in CDCl3. The NMR in DMSO was hard to analyze.
3-Hydroxy-4,5,7-triiodo-2-octanoyl-6-fluorone (10, 0.1 mmol) was dissolved in 3 ml of DMF. KCN (0.3 mmol) was added and the mixture was stirred for 1 hour at room temperature. It was then poured into a dilute solution of HCl to form a purple precipitate. This precipitate was filtered and washed with water giving 9-cyano-3-hydroxy-2-octanoyl-4,5,7-triiodo-6-fluorone in 88% yield. This compound showed very good solubility in CDCl3. 1 HNMR (CDCl3): 13.93 ppm (1H,s), 8.23 (1H,s), 8.18 (1H,s), 3.15 (2H,t,J=7.3 Hz), 1.7-1.9 (2H,m), 1.2-1.6 (8H,m), 0.94 (3H,t).
The synthesis of 2,7-disubstituted fluorones is shown in Synthesis Examples 24-2.
8.0 ml of 15-18% fuming sulfuric acid was added dropwise to 3,6-dihydroxyxanthane (10.7 g, 50 mmol.) in 50.0 ml of 2-methyl-2-propanol. The mixture was stirred for 30 minutes and then heated to reflux for one hour. Thereafter 15.0 ml of 2-methyl-2-propanol was added and the solution was refluxed for another 2.5 hours. Upon cooling, the precipitate which formed was filtered and washed with water. 2,7-di-t-butyl-3-hydroxy-6-fluorone (15.8 g) was obtained in 97.5% yield. HNMR(DMSO): 9.11(s,1H), 7.89(s,2H), 7.05(s, 2H), 1.43(s, 18H).
Iodic acid (352 mg, 2.0 mmol) dissolved in a minimum amount of water was added dropwise to a solution of 1.62 g (5.0 mmol.) of 2,7-di-t-butyl-3-hydroxy-6-fluorone and 1.27 g (10.0 mmol) of iodine in 50 ml of absolute ethanol at 0° C. This mixture was stirred over two hours then 50 ml of cool water was added. The precipitate which formed was filtered and washed with a small amount of ethanol. 2,7-di-t-butyl-yield. HNMR (DMSO): 8.21(s,1H), 7.55(s,2H), 1.38(s,18H).
Fuming sulfuric acid (3.0 ml of 15-18%) was added dropwise to 2,7-di-t-butyl-3-hydroxy-6-fluorone (1.6 g, 4.9 mmol.). The mixture was stirred until the compound dissolved it was slowly warmed to 40°-50° C. for half hour. Ice (10-15 g) was carefully added to the resulting mixture at 0° C. with stirring. The precipitate which formed was filtered and 2,7-di-t-butyl-4,5-disulfuryl-3-hydroxy-6-fluorone (1.72 g) was obtained in 72% yield. HNMR (DMSO): 9.7(s,1H), 8.17(s,2H), 1.40(s,18H).
As the foregoing examples and Reaction Scheme 1 illustrate, the 2- and 7- positions can be functionalized by an electrophilic substitution reaction. Subsequently, the 9-position is functionalized by a 1,6-conjugated addition reaction followed by autooxidation. See for example compounds 8 and 9 in Reaction Scheme 1.
Introduction of functional groups at the 4 and 5 positions may also be accomplished by electrophilic substitution. From 2,7-di-t-butyl-3-hydroxy-6-fluorone, compound 5 in Reaction Scheme 1, 2,7-di-t-butyl-3-hydroxy-4,5-diiodo-6-fluorone can be prepared by reaction with iodine and HIO3. 2,7-Di-t-butyl-3-hydroxy-4,5-disulfuryl-6-fluorone can be prepared from compound 5 by reaction with 15-18% fuming sulfuric acid. Each of these derivatives can be reacted with KCN in DMF using the procedure of Synthesis Example 10 to yield the corresponding 9-cyano derivative.
The 4- and 5-positions can be functionalized as shown in Scheme 2. ##STR8##
Other 4,5- derivatives can be prepared from 3-hydroxy-4,5-diiodo-6-fluorone (DIHF) which can be prepared as shown in Scheme 3 and illustrated in Synthesis Examples 27 and 28 below: ##STR9##
To a suspension of 3,6-dihydroxy-4,5-diiodoxanthone (9.6 g, 20.0 mmol) in 100 ml of THF was added 40 ml of boran-tetrahydrofuran complex (1.0M in THF) at room temperature under nitrogen. After stirring for 5 hours at room temperature, the reaction mixture was quenched by adding 20.0 ml of 0.5N HCl. After stirring for 30 minutes the solvent was removed. The residue was filtered and the precipitate was dissolved in the 0.1N NaOH solution. This basic solution was filtered and acidified with 0.5N HCl. The yellow solid product which formed was filtered. 3,6-dihydroxy-4,5-diiodoxanthane (9.2 g, 96.6%) was obtained. HNMR (DMSO): 10.38(s,2H), 2.05 (d,2H, J=8.3 Hz), 6.67(d,2H, J=7.8 Hz), 3.88(s,2H).
To a solution of 3,6-dihydroxy-4,5-diiodoxanthane (233 mg 0.5 mmol) in 10 ml of ethanol at 25° C. was added 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (113 mg, 0.5 mmol). The reaction mixture was stirred for 4 hours at room temperature. The yellow precipitate was filtered and washed with ethanol. 4,5-Diiodo-3-hydroxy-6-fluorone (180 mg) was obtained in 77.6% yield. HNMR (DMSO): 8.22(s,1H), 7.68(d,2H, J=8.8 Hz), 6.84(d,2H, J=8.3 Hz).
A general procedure for preparation of 9-cyano substituted xanthene derivatives as provided in Example 29.
Potassium cyanide (2.0 mmol) was added to a solution of the corresponding 9-hydrogen substituted xanthene (1.0 mmol) in 5.0 ml of DMF. The reaction was monitored by the visible absorption spectrum until the starting material was completely consumed. The reaction solution was treated with 4:1 hexane:dichloromethane after which the precipitate which formed was filtered, dried and treated with 5% HCl and washed with water. 9-Cyano substituted fluorone derivatives were obtained in 80-95% yield. Analytically pure compounds were isolated by TLC separation. The compounds had the properties shown in the table:
______________________________________ Compound HNMR (DMSO) ______________________________________ 9-Cyano-3-hydroxy-6-fluorone 7.28(d, 2H, J=9.24 Hz), 6.28 (dd, 2H, J=9.24, 1.92 Hz), 5.94 (d, 2H, J=1.98 Hz) 9-Cyano-2,4,5,7-tetra-t- 7.79(s, 2H) butyl-3-hydroxy-6-fluorone 9-Cyano-2,4,5,7-tetraiodo- 8.01(s, 2H) 3-hydroxy-6-fluorone 9-Cyano-4,5-diiodo-3- 7.38(d, 2H, J=9.2 Hz), 6.46 hydroxy-6-fluorone (d, 2H, J=9.2 Hz) 9-Cyano-2,7-Di-t-butyl- 7.41(s, 2H), 1.37(s, 18H) 3-hydroxy-6-fluorone 9-Cyano-2,7-di-t-butyl- 7.28(s, 2H), 1.34(s, 18H) 4,5-diiodo-3-hydroxy- 6-fluorone ______________________________________
The synthesis of 2-octyl-4,5,7-triiodo-3-hydroxy-6-fluorone and its 9-cyano derivative is shown in Examples 30-33.
2-Octanoyl-3,6-dimethoxy xanthane (2 mmol) was dissolved in a mixture of 15 ml of ethanol, 16 ml of ethanol, 16 ml of dichloromethane, 1 ml of water and 0.6 ml of conc. HCl. To this mixture, 0.6 g of activated carbon containing 10 wt % of palladium was added. After stirring overnight under a hydrogen atmosphere, the activated carbon was filtered out and washed with chloroform. The solution was washed with water using a separate funnel. The organic solvents were removed under reduced pressure and the remaining 2-octyl-3,6-dimethoxy xanthane was purified using column chromatography. The yield was 83%.
1 H NMR (CDCl3): 7.05 ppm(1H,d,8.8 Hz), 6.88(1H,s), 6.60(1H,dd,8.3 Hz, 2.4 Hz), 6.58(1H,s),6.54(1H,s), 3.90(2H,s), 3.80(6H,s), 2.54(2H,t,7.2 Hz), 1.2-1.4(12H,m), 0.9(3H,t) MS m/e for C23 H30 O3 : Calcd: 354.49: Measured: 354.15
3,6-dimethoxy-2-octyl xanthane (1.2 mmol), was dissolved in a mixture of 5 ml of ethanethiol and 20 ml of anhydrous dichloromethane. After cooling in a dry ice/EtOH bath, 6 mmol of aluminum chloride was added. The reaction mixture was stirred gradually warming to room temperature overnight. It was then poured into a mixture of 20 g of ice and 10 ml of conc. HCl. The dichloromethane was removed under reduced pressure. The residue was dissolved in aqueous NaOH solution. The solution was then poured into dilute HCl to obtain a precipitate. The precipitate was finally filtered, washed with water to yield in 94%. 1 H NMR suggested that the compound was a mixture (mp=130°-135° C.) of compounds 3,6-dihydroxy-2-octylxanthane (77%) 6.96 ppm(1H,s), 6.82(1H,s), 6.50-6.52(3H,m), 3.82(2H,s) and an oxidized fluorone form 7.96 ppm (1H,s), 7.53(1H,d,9.3 Hz), 7.41(1H,s), 6.92(2H,s), 6.71(1H,s). Further purification was not attempted because both compounds were thought to yield the same compound the triiodofluorone in the next step. 1 H NMR in CDCl3 /DMSO=10/1 (only for the aromatic ring).
The product of Synthesis Example 31 (0.3 mmol) and iodine (0.3 mmol) were dissolved in 3 ml of ethanol. An aqueous solution of iodic acid (0.3 mmol in 0.2 ml of water) was added at room temperature. The reaction mixture was stirred at refluxing temperature for 1 hour. The resulting red precipitate was filtered, washed with ethanol and water mixture to obtain the title compound in 71% yield. 1 H NMR (DMSO): 8.45 ppm(1H,s), 8.20 (1H,s), 7.61(1H,s), 2.67(2H, t, 7.6 Hz), 1.5-1.6(2H, m), 1.1-1.4(10H,m), 0.85(3H, t, 6.6 Hz).
The Product of Example 32 (0.135 mmol) was dissolved in 3 ml of DMF. KCN (0.5 mmol) was added and the reaction mixture was stirred at room temperature. The conversion was monitored with a spectrometer. After 2 hours stirring, the mixture was poured into dilute HCl. The title compound was extracted with chloroform. The chloroform solution was washed with water several times to remove DMF. The chloroform was removed yielding 73% of pure compound. 1 H NMR (DMSO): 8.14 ppm(1H,s), 7.44(1H,s), 3.14 (2H, t, 7.0 Hz), 0.8-1.6(15H, m). λmax (in EtOH with K2 CO2)=630 nm.
The absorption wavelengths of 7-unsubstituted, 7-octanoyl- and 7-octyl-substituted TICHF were 636 nm, 638 nm and 630 nm, respectively. An electron withdrawing acyl group shifted only 2 nm to blue and an electron donating alkyl group shifted 6 nm to red. Substitution on the aromatic ring does not seem to change significantly the maximum absorption wavelength.
Compounds of the general formula (IV) may be obtained by aminomethylation of the corresponding fluorone followed by functionalization of the 9-position or by functionalization of pyronin y using reactions which are analogous to those shown in Reaction Scheme 1 for the fluorones.
Compounds of the formula VI can be prepared by the following Scheme 4: ##STR10##
A proposed synthesis for 9-trifluoromethyl derivatives is provided in Scheme 5: ##STR11##
When W is ═O and W1 is hydrogen, the compounds are herein referred to as dehydroxyfluorones. A proposed synthetic route for dehydroxyfluorones is shown in Scheme 6 below. ##STR12##
The compounds of the present invention are useful in many of the same applications as conventional photoinitiators and fluorescent dyes. In particular, they are useful as a substitute for fluorescein dyes and other fluorescent agents in immunoassays and still more particularly in polarization immunoassays of the type described in U.S. Pat. No. 4,585,862. The compounds are advantageous because they absorb at much longer wavelengths than conventional fluorescers and this enables the use of inexpensive lasers such as He/Ne lasers to excite the compounds. Furthermore, because of their long absorption wavelengths, it may be possible to perform immunoassays on whole blood using these compounds. Presently, it is generally necessary to remove the blood cells from the blood in order to prevent them from absorbing the excitation energy.
The compounds of the invention are also useful as fluorescent oil additives for use in engine leak detection. Presently, the fluorescent dyes used in this process require the use of high powered lamps to excite the dye and in order to produce a sufficient level of fluorescence to detect oil leakage due to the competing absorption of the oil and the oil additives. Because the compounds of the invention absorb at longer wavelengths, less competing absorption is encountered and lower power light sources can be used to detect oil leakage. The other components of the oil do not compete as much for the light at longer wavelengths. A particularly preferred fluorescer for use in leak detection is 2,7-di-t-butyl-3-hydroxy-6-fluorone, Compound No. 5 in Reaction Scheme 1 above.
As a result of this photobleachable character, the compositions are also useful in applications in which clear or translucent layer is required as in providing protective coatings for decorative surfaces such as wall and floor panels and in applications in which a high depth of cure is desired.
The fluorone initiators are preferably used in combination with a coinitiator. Coinitiators useful in the present invention can be selected from among those known in the art and, more particularly, from known electron donating coinitiators. N-phenylglycine (NPG) is a well known and preferred coinitiator. Examples of other useful electron donating coinitiators are discussed in Eaton, D. F., "Dye Sensitized Photopolymerization", Advances in Photochemistry, Vol. 13, pp. 427-486. N,N-dialkylanilines are also particularly useful. Other tertiary amines such as diethanolamine, triethanolamine, and arylsulfinates can also be used.
Dialkylanilines appear to function as autoxidizers and are preferably used in combination with an electron donor such as NPG. Representative examples of N,N-dialkylanilines useful in the present invention are diisopropyldimethylaniline (DIDMA), 4-cyano-N,N-dimethylaniline, 4-acetyl-N,N-dimethylaniline, 4-bromo-N,N-dimethylaniline, 4-methyl-N,N-dimethylaniline, 4-ethoxy-N,N-dimethylaniline, N,N-dimethylthioaniciidine, 4-amino-N,N-dimethylaniline, 3-hydroxy-N,N-dimethylaniline, N,N,N'N'-tetramethyl-1,4-dianiline, 4-acetamido-N,N-dimethylaniline, 2,6-diethyl-N,N-dimethylaniline, N,N,2,4,6-pentamethylaniline (PMA) and p-t-butyl-N,N-dimethylaniline.
Another class of useful coinitiators is alkyl borate salts such as ammonium and pyridinium salts of tetrahydrocarbyl boranyl anions. Useful boranylanions are disclosed in U.S. Pat. No. 4,772,541.
The most typical example of a free radical addition polymerizable or crosslinkable compound useful in the present invention is an ethylenically unsaturated compound and, more specifically, a polyethylenically unsaturated compound. These compounds include both monomers having one or more ethylenically unsaturated groups, such as vinyl or allyl groups, and polymers having terminal or pendant ethylenic unsaturation. Generally, any unsaturated compound which is convertible to a solid by free radical polymerization is useful herein. Such compounds are well known in the art and include acrylic and methacrylic esters of polyhydric alcohols such as trimethylolpropane, pentaerythritol, and the like; and acrylate or methacrylate terminated epoxy resins, acrylate or methacrylate terminated polyesters, etc. Representative examples include ethylene glycol diacrylate, ethylene glycol dimethacrylate, trimethylolpropane triacrylate (TMPTA), pentaerythritol tetramethacrylate, dipentaerythritol hydroxypentacrylate (DPHPA), hexanediol-1,6-dimethacrylate, hexanediol diacrylate, diethyleneglycol dimethacrylate, diglycidyl ether diacrylate (MW=390), trimethylol propane ethoxylate triacrylate, neopentyl glycol propoxylate diacrylate, tripropylene glycol diacrylate (MW=300)(TPGDA). Other vinyl compounds such as N-vinyl pyrrolidone (NVP) are also useful. The monomers may be selected and blended to provide the optimum photographic speed and/or the physical characteristics desired in the product. Monomer selection and blending may also be used to insure adequate solubility of the photoinitiators.
It may be desirable to incorporate a sensitizer in the compositions of the present invention to control the sensitivity of the composition and/or to extend its sensitivity. Useful sensitizers include those known in the art such as anthracene, and its derivatives naphthalene, acetophenone, benzophenone, 2-acetonaphthone, etc.
Solvents may be necessary to dissolve the photoinitiator if the photoinitiator is not sufficiently soluble in the monomer. Solvents may also be used to shift the absorption spectrum to tune the sensitivity of the composition. Some examples of useful solvents are N-vinylpyrrolidone and nitrobenzene. Other useful solvents can be identified readily.
The nature of the monomer, the amount of the fluorone and coinitiator in photohardenable compositions in accordance with the present invention will vary with the particular use of the compositions, the emission characteristics of the exposure sources, the development procedures, the physical properties desired in the polymerized product and other factors. With this understanding, compositions in accordance with the invention will generally fall within the following compositional ranges in parts by weight (based on 100 parts total):
______________________________________ Polymerizable compound 50 to 99.7 Fluorone 0.01 to 0.20 Electron Donor 0.2 to 4 Autoxidizer 0 to 3 Sensitizer (optional) 0.3 to 1. ______________________________________
Compositions in accordance with the invention more typically are anticipated to have the following formulation:
______________________________________ Polymerizable compound 10 Fluorone .002 to .010 Electron Donor .02 to .1 Autoxidizer 0 to 3 g Sensitizer (optional) .02 to .1 ______________________________________
Examples of some photosensitive compositions incorporating photoinitiators in accordance with the invention are provided in Example 35.
The following compositions were prepared:
______________________________________ Composition 1 TMPTA 90 g NVP 10 g TIHF 3.6 mg NPG 75 mg Composition 2 DPHPA 87 g NVP 13 g NPG 3.6 mg TIHF 75 mg Composition 3 DPHPA 30 g NVP 10 g TIHF 3.6 mg NPG 75 mg TMPTA 20 g Ebecryl 3700 4 oz. (bisphenol A diacrylate) Composition 4 NVP 10 g TIHF 3.6 mg NPG 75 mg Tetraethylene glycol diacrylate 90 g ______________________________________
Results
Each composition was placed in a test tube and exposed to a broad band light source. The compositions all cured rapidly.
In addition to being useful in photosensitive materials, the compositions of the present invention are also useful in a wide variety of other applications including photocurable inks and coatings, photoadhesives, printing plates, printed circuit fabrication, and other applications for photohardenable compositions.
One of the advantages of the fluorone dye photoinitiators in this invention is the depth of the cure that is obtainable. This is in contrast to UV photoinitators that causes a "screening" effect which prevents the UV light from penetrating beyond a certain minimum depth, usually several millimeters. By contrast, the fluorone dye bleaches as it photoinitiates and is concommitantly converted into a non-visible absorbing species thus allowing more visible light to penetrate which continues the cure. This cascading bleaching effect permits substantial depth of cure which can easily reach several inches.
An acrylate monomer mixture was composed of 15 parts urethane diacrylate, 20 parts TPGPA, 40 parts TMPTA and 15 parts DPHPA, and a 20 to 1 weight ratio of NPG coinitiator to DIEF or DIBF fluorone dye. For dye concentrations of 0.01, 0.05 and 0.1 weight, all the formulations cured to a depth of 3 cm in 30 seconds when exposed to a 350 watt tungsten halogen light which provides about 500 mw/cm2 irradiance. When the irradiance was increased to about 2 watts/cm2 cure speed was shortened to 5 seconds for the same depth.
An acrylate mixture was composed of 60% urethane diacrylate, 30% DPHPA, 10% BDDA, and 0.05 weight % of DIEF or DIBF fluorone dye with 2 weight % of DIDMA. The formulation cure to a depth greater than 1 cm in 10 seconds when exposed to a 75 watt tungsten halogen lamp which provided an irradiance of about 260 mw/cm2.
An acrylate mixture was composed of 33% TMPTA, 33% DPHPA, 33% Epoxy acrylate, and 2% of DIDMA with either 0.01, 0.05 or 0.1 weight % of DIEF. All samples cured to a depth greater than 1 cm in 10 seconds when exposed to a 75 watt tungsten halogen.
An acrylate mixture was composed of 70% urethane diacrylate, 5% DPHPA, 25% BDDA, and 2% DIDMA with either 0.01, 0.03 or 0.1 weight % DIEF. The 0.01 and 0.03 samples cured after 2 passes through a 300 watt per inch medium pressure mercury arc lamp at a speed of 50 feet/minute to a depth greater than 3 mm. The 0.1 sample cured to a depth of greater than 1.5 mm.
The depth of cure results have also been observed with other fluorone dyes as part of this invention that absorb throughout the visible spectrum inlcuding TIHF and TIHCF.
While the invention has thus far been described with regard to free radical polymerizable compositions, the fluorones described herein are also useful in ionically polymerizable compositions and more particularly cationically polymerizable compositions. The fluorones may be used in combination with onium salts such as iodonium, phosphonium, sulfonium and pyrylium salts. Compositions containing onium salts are capable of generating free radicals as well as cations and may be used to provide photohardenable compositions which react by either or both mechanisms. The fluorone may react as an electron donor or as an electron acceptor depending upon the nature of the coinitiator and onium salt (if present). In free radical polymerizable composition such as those illustrated in Example 34, the fluorone is an electron acceptor whereas in compositions such as those illustrated in Examples 35-37 below and in cationic polymerization the fluorone is believed to react as an electron donor.
Cationically polymerizable compositions based upon onium salts are known in the art as shown in U.S. Pat. Nos. 4,264,703 and 4,307,177 to Crivello, and European Application 0 408 227 A1.
Examples of onium salts useful in the invention can be found in published European Patent Application 0 408227A1. The preferred onium salts for use in the invention are diphenyliodonium salts such as diphenyliodonium hexafluorophosphate, arsenates, antimonates, etc., and, more particularly, hexafluoro-antimonate. Onium salts of simple anions such as chlorides, bromides, etc. are also useful in free radical polymerizable compositions. A particularly preferred onium salt is OPPI below. Addition of a coinitiator such as NPG improves film speed, pencil hardness and double bond conversion. A particularly preferred initiator system is a combination of an iodofluorone in accordance with the invention such as TIHF or DIBF, an amine such as NPG or DIDMA and an onium salt. A preferred molar ratio of fluorone to onium salt to amine is about 1:2:3. Keeping this ratio constant, the double bond conversion has been observed to increase as the molar concentration of the fluorone increases from 0.001 to 0.003 molar. These onium salt formulations are illustrated in the following Examples 35-37.
In accordance with one embodiment of the invention the fluorone may be metathesized with an onium salt to form an ionically bonded complex of one or two onium cations and the fluorone dye anion. Complex formation occurs at the 6-position when W═O as well as at the 3-position when W1 is O- in formula (III).
To a resin formulation consisting of 15 parts urethane diacrylate, 15 parts DPHPA, 20 parts TPGDA and 40 parts TMPTA was added DIDMA, initiator and (4-octyloxyphenyl)phenyliodonium hexafluoroantimonate (OPPI). The samples were coated to a thickness of 15 microns and exposed to a 75 W tungsten halogen dental lamp (focused through an optical fiber) at a distance of 0.75 inch at which the light intensity was about 0.40 W/cm2. The molar ratios are indicative of the amounts of fluorone to onium salt to amine coinitiator. The double bond conversion was determined by FTIR spectroscopy. The pencil hardness of a given test sample is measured by holding a pencil at a 45° angle to the sample and drawing across it towards the person testing it. Using the pencils in an order from softest to hardest, the first pencil that scratches the surface is assigned as the pencil hardness of the sample. The pencil hardness scale is as follows from softest to hardest: 4B, 3B, 2B, B, HB, H, 2H, 3H, 4H, 6H. For instance, if a 2H pencil is the first pencil to scratch the surface then the pencil hardness is 2H.
At the extreme ends of the scale, it is impossible to determine the actual pencil hardness. If the 6H pencil does not scratch the sample, the only assignment that can be made is that it is >6H. Likewise, if the 4B pencil scratches the sample, the only assignment that can be made is <4B, unless it is a lot softer than 4B in which case a <<4B can be assigned. A pencil hardness of 4H is generally considered satisfactory. Pencil hardness data was greater than 6H after 30 seocnd exposure for all samples except for the control samples without amine (1:2:0). The controls were all less than 4B at 0.05 wt %, 0.10 wt %, and 0.15 wt %. The results are shown in Table 4.
TABLE 4 ______________________________________ Molar Exp. C = C % Initiator CONC. Ratio Coinitiator Time Conversion ______________________________________ DIBF 0.05 wt % (1:2:0) DIDMA 30 sec 5% DIBF 0.10 wt % (1:2:0) DIDMA 30 sec 18% DIBF 0.15 wt % (1:2:0) DIDMA 30 sec 19% DIBF 0.05 wt % (1:0:60) DIDMA 30 sec 37% DIBF 0.05 wt % (1:1:60) DIDMA 30 sec 37% DIBF 0.05 wt % (1:2:3) DIDMA 30 sec 40% DIBF 0.05 wt % (1:2:5) DIDMA 30 sec 40% DIBF 0.05 wt % (1:2:60) DIDMA 30 sec 43% DIBF 0.05 wt % (1:2:3) NPG 30 sec 40% DIBF 0.05 wt % (1:2:3) DIDMA 30 sec 40% DIBF 0.10 wt % (1:2:3) DIDMA 30 sec 45% DIBF 0.15 wt % (1:2:3) DIDMA 30 sec 50% DIBF 0.20 wt % (1:2:3) DIDMA 30 sec 51% DIBF 0.25 wt % (1:2:3) DIDMA 30 sec 50% DIBF 0.05 wt % (1:2:3) NPG 60 sec 43% DIBF 0.05 wt % (1:2:3) DIDMA 60 sec 43% DIBF 0.10 wt % (1:2:3) DIDMA 60 sec 47% DIBF 0.15 wt % (1:2:3) DIDMA 60 sec 54% DIEF 0.05 wt % (1:2:3) DIDMA 30 sec 40% DIOF 0.15 wt % (1:2:3) DIDMA 30 sec 40% DIOF 0.05 wt % (1:2:3) DIDMA 30 sec 40% ______________________________________
The foregoing study was repeated using 100% butanediol diacrylate, and 100% polyethylene glycol diacrylate (MW=400)(PEGA 400). The results are shown in Table 5 that follows:
TABLE 5 ______________________________________ Molar Exp. C = C % Initiator CONC. Ratio Coinitiator Time Conversion ______________________________________ 100% Butane Diol Diacrylate (BDDA): DIBF 0.05 wt % (1:0:60) DIDMA 30 sec 30% DIBF 0.05 wt % (1:2:3) DIDMA 30 sec 49% DIBF 0.10 wt % (1:2:3) DIDMA 30 sec 56% DIBF 0.10 wt % (1:2:3) DIDMA 60 sec 56% DIBF 0.15 wt % (1:3:3) DIDMA 30 sec 58% 100% Polyethylene Glycol Diacrylate (PEGA400) DIBF 0.05 wt % (1:0:60) DIDMA 60 sec 50% DIBF 0.05 wt % (1:2:3) DIDMA 60 sec 61% DIBF 0.10 wt % (1:2:3) DIDMA 60 sec 90% DIBF 0.15 wt % (1:2:3) DIDMA 60 sec 90% DIBF 0.15 wt % (1:2:3) DIDMA 30 sec 84% DIBF 0.15 wt % (1:2:3) DIDMA 10 sec 60% ______________________________________
Photosensitive compositions were prepared from the resin formulation of Example 35 containing 1% NPG and 0.05% DIBF or 0.05% DIEF. The samples were exposed under the conditions shown in the following table and pencil hardness was measured. The results are shown in Table 6.
TABLE 6 ______________________________________ 0.05 wt. % 0.05 wt. % Light Source Conditions Time DIBF DIEF ______________________________________ Dental Lamp No Air 60 sec >6 H 3 H Dental Lamp No Air 30 sec >6 H 2 H Dental Lamp No Air 10 sec 4 H <4 B Dental Lamp Air 60 sec H 2 B Fusion (Q bulb) Air 10 ft/min >6 H >6 H Fusion (Q bulb) Air 20 ft/min 4 H 3 H Overhead Proj. No Air 60 sec 5-6 H 3 H Overhead Proj. Air 60 sec H 3 B ______________________________________
Diphenyliodonium hexafluoroantimonate was added to DIBF samples. The results are shown in Table 7.
TABLE 7 ______________________________________ 0.05 wt. % DIBF (w/0.05 wt. % Light Source Conditions Time DPISbF6) ______________________________________ Dental Lamp No Air 10 sec >6 H Dental Lamp Air 60 sec 2 H Fusion (Q bulb) Air 10 ft/min >6 H Fusion (Q bulb) Air 20 ft/min >6 H ______________________________________
Samples were also prepared using 1% DIDMA in addition to the fluorone for a 20:1 weight ratio. The exposure conditions and pencil hardness are shown in the following Table 8.
TABLE 8 ______________________________________ 0.05 wt. % 0.05 wt. % Light Source Conditions Time DIBF DIEF ______________________________________ Dental Lamp No Air 60 sec >6 H 2 B Dental Lamp No Air 30 sec >6 H 3 B Dental Lamp No Air 10 sec 5-6 H (not tested) Dental Lamp Air 60 sec H 3 B Fusion (Q bulb) Air 10 ft/min >6 H 2 B Fusion (Q bulb) Air 20 ft/min 3 H >4 B ______________________________________
Samples were also prepared from the same resin formulation containing 0.1% DIBF in addition to the coinitiator listed in the following Table 9 with the exposure condition and pencil hardness results shown.
TABLE 9 ______________________________________ Light 1.5% 1.5% Source Conditions Time DIDMA NPG 2% NPG ______________________________________ Dental No Air 60 sec >6 h >6 h >6 H Lamp Dental No Air 30 sec >6 H >6 H >6 H Lamp Dental No Air 10 sec >6 H 5-6 H 5-6 H Lamp Dental Air 60 sec H H H Lamp Fusion Air 10 ft/min >6 H >6 H >6 H (Q bulb) Fusion Air 20 ft/min 5-6 H 5-6 H 5-6 H (Q bulb) ______________________________________
Using the resin formulation of Example 36, photosensitive compositions were prepared using TIHF, DIDMA and OPPI at a concentration of 0.21% and in the molar ratios shown in Table 10 which follows. Exposure was conducted with the dental lamp at a distance of 1 inch from the sample to provide an intensity of about 0.26 W/cm2. Molar ratios are fluorone:onium salt:amine.
TABLE 10 ______________________________________ Molar Ratio Exp. Time Pencil Hardness ______________________________________ (1:1:0) 60 sec. 4 H (1:2:0) 60 sec. 5-6 H (1:5:)) 60 sec. 5-6 H (1:10:0) 60 sec. 5-6 H (1:1:0) 60 sec. 4 H (1:1:1) 60 sec. 5-6 H (1:1:5) 60 sec. >6 H (1:1:10) 60 sec. >6 H (1:1:33) 60 sec. >6 H (1:2:0) 60 sec. 5-6 H (1:2:10) 60 sec. >6 H (1:2:5) 60 sec. >6 H (1:2:10) 60 sec. >6 H (1:2:33) 60 sec. >6 H ______________________________________
TABLE 11 ______________________________________ Conc. Molar Ratio Coinitiator Exp. Time Pencil Hardness ______________________________________ 0.05% (1:2:3) NPG 60 sec. >6 H 0.05% (1:2:3) DIDMA 60 sec. >6 H 0.10% (1:2:3) DIDMA 60 sec. >6 H 0.15% (1:2:3) DIDMA 60 sec. >6 H 0.05% (1:0:60) DIDMA 60 sec. >6 H 0.05% (1:0:60) DIDMA 60 sec. >6 H 0.05% (1:0:60) DIDMA 10 sec. 4 H 0.05% (1:1:60) DIDMA 10 sec. >6 H ______________________________________
This example illustrates the preparation of an onium salt complex from TIHF and diphenyliodonium chloride.
7.15 g TIHF was washed with diluted HCl solution and subsequently washed with a large quantity of H2 O to make sure all the dye is in the acidic form. The TIHF was dissolved in 65 Ml DMF. Fresh Ag2 O was prepared by mixing approximately equimolar aqueous solutions of AgNO3 and NaOH together, the precipitated black Ag2 O was filtered and washed with large quantity of distilled water. 2.2 g moist Ag2 O and 3.5 g diphenyliodonium chloride were mixed together in a glass mortar. The reagents were thoroughly ground together until no trace of iodonium compound could be discerned. The black slurry was then washed into a sintered glass filter and the precipitate washed with H2 O until 35 ml filtrate was obtained. The filtrate was filtered again until the solution of diphenyliodonium hydroxide was transparent. The DMF solution of TIHF and the aqueous solution of diphenyliodonium hydroxide was mixed together and the DMF/H2 O solvent was vacuum distilled off until only a small volume remained. The dye onium complex salt was precipitated from the solution by adding a large quantity of H2 O, and dried in an oven at 60° C. overnight. The yield is 80%.
The photohardenable compositions of the present invention can be coated upon a support in a conventional manner and used in making a photoresist or in photolithography to form an oleophilic polymer image. Development of photohardenable compositions in accordance with the invention is conducted in an otherwise known or conventional manner, e.g., a solvent for the unpolymerized monomer may be used to remove the photohardenable composition in the unexposed areas.
The compositions of the invention can also be encapsulated as described in U.S. Pat. Nos. 4,399,209 and 4,440,846 and used to control the release of an image-forming agent. The latter processes typically involve image-wise exposing the photosensitive layer to actinic radiation and subjecting the layer of microcapsules to a uniform rupturing force such as pressure.
The photohardenable composition of the invention are also advantageous for use in the three dimensional modeling process taught in U.S. Pat. No. 4,575,330 to Hull. Due to the thicker depth of cure that is possible, models may be prepared in larger cross-sectional increments. This should reduce the total time required for the model building process. Another advantage which the claimed compounds bring to three dimensional modeling is higher green strength.
Generally, fluorones in accordance with the invention absorb at about 360 to 635 nm. It is anticipated that sensitivity can be extended to longer wavelengths by substituting electron donating groups for R. Depending upon the extinction coefficient, compositions and photosensitive materials in accordance with the invention can be exposed to any source which emits in this range and particularly an He/Cd laser, or mercury arc lamps.
The invention also includes the use of fluorones in dosimeters and more particularly in dosimeters useful in wave length sensitive laser dosimeters.
Having described the invention in detail and by reference to preferred embodiments thereof, it will be apparent that modifications and variations are possible without departing from the scope of the invention defined in the appended claims.
Claims (13)
1. A photohardenable composition comprising a polymerizable compound and a compound of the formula I or II ##STR13## where R1, R2, R5 and R6 are the same or different and represent a hydrogen atom or a halogen atom and R1 and R2 can combine to form a ring; R3 and R4 are the same or different and represent a hydrogen atom, a halogen atom, a benzoyl group, a group of the formula --L(CH2)n R8 where n is 1 to 8, R8 is hydrogen, hydroxy, amino, dialkylamino, --COR16 or --COOR14 where R16 is hydrogen, chlorine, COCl, C1-C8 alkyl, NR2 or aryl and R14 is hydrogen, C1-C8 alkyl, aryl, COR, 2,4-dinitrophenyl, N-imido or NR2 and L is a direct bond or >C═O, provided that at least two of R1 -R6 are iodo or bromo; W is ═O or ═NR2 +Z-- where R is hydrogen or lower alkyl, Z is a counter ion, when W is ═O, W1 is hydrogen or --OR9 where R9 is hydrogen, C1-C8 alkyl, acyl or a group of the formula --(CH2)n R10 where n is 1 to 8 and R10 is amino, dialkylamino, hydroxy, acryloyl or methacryloyl and when W is ═NR2 +Z--, W1 is hydrogen or --NR2 ; Y is oxygen, sulfur, selenium, tellurium, >C═O, or N--R13 where R13 is 4-methylphenyl, A is hydrogen, alkenyl, alkyl, or an electron withdrawing group (EWG) selected from the group consisting of COOR11, COR12, C(O)OCOR11, CONR2, CN, NO2, NCS, NCO, SO2 R12, SO3 R11, SO2 NR2, CX3 2 ; R11 is hydrogen, alkyl, aryl, or aralkyl R12 is hydrogen, alkyl, aryl, or aralkyl, X2 can be the same or different and is a halogen atom.
2. The composition of claim 1 wherein said compound is represented by the Formula (I).
3. The composition of claim 2 wherein said compound is represented by the Formula (III) or (IV) ##STR14## where Y1 is oxygen, sulfur or >NR13.
4. The composition of claim 3 wherein X1 is 0.
5. The composition of claim 4 wherein said compound is represented by the Formula (III).
6. The composition of claim 5 wherein A is hydrogen.
7. The composition of claim 5 wherein A is CN.
8. The composition of claim 5 wherein said composition includes a coinitiator capable of accepting an electron from or donating an electron to said compound.
9. The composition of claim 8 wherein said conitiator is N-phenylglycine or an N,N-dialkylaniline.
10. The composition of claim 9 wherein said compound is selected from the group consisting of
5,7-diiodo-3-methoxy-6-fluorone (DIMF),
5,7-diiodo-3-ethoxy-6-fluorone (DIEF),
5,7-diiodo-3-butoxy-6-fluorone (DIBF),
5,7-diiodo-3-octoxy-6-fluorone (DIOF),
4,5-diiodo-3-hydroxy-6-fluorone,
9-cyano-5,7-diiodo-3-methoxy-6-fluorone (CDIMF),
9-cyano-5,7-diiodo-3-ethoxy-6-fluorone (CDIEF),
9-cyano-5,7-diiodo-3-butoxy-6-fluoorone (CDIBF),
9-cyano-5,7-diiodo-3-octoxy-6-fluorone (CDIOF),
3-hydroxy-2,4,5,7-tetraiodo-6-fluorone (TIHF),
3-hydroxy-2,4,5,7-tetrabromo-6-fluorone (TBHF),
3-hydroxy-2,4,5,7-tetrachloro-6-fluorone (TCHF),
3-hydroxy-2,4,5,7-tetrafluoro-6-fluorone (TFHF),
9-cyano-3-hydroxy-2,4,5,7-tetraiodo-6-fluorone (TIHCF),
9-cyano-3-hydroxy-2,4,5,7-tetrabromo-6-fluorone (TBHCF),
9-cyano-3-hydroxy-2,4,5,7-tetrachloro-6-fluorone (TCHCF),
9-cyano-3-hydroxy-2,4,5,7-tetrafluoro-6-fluorone (TFHCF),
3-hydroxy-4,5,7-triiodo-2octanoyl-6-fluorone,
9-cyano-3-hydroxy-4,5,7-triiodo-2-octanoyl-6-fluorone,
3-hydroxy-4,5,7-triiodo-2-octanoyl-6-fluorone,
9-cyano-3-hydroxy-4,5,7-triiodo-2-octyl-6-fluorone,
3-hydroxy-2,4,5,7-tetraiodo-6-thiafluorone,
3-hydroxy-4,5,7-triiodo-2-pentanoyl-6-fluorone,
9-cyano-3-hydroxy-4,5,7-triiodo-2-pentanoyl-6-fluorone,
3-hydroxy-4,5,7-triiodo-2-pentyl-6-fluorone,
9-cyano-3-hydroxy-4,5,7-triiodo-2-pentyl-6-fluorone,
2,7-di-t-butyl-4,5-diiodo-3-hydroxy-6-fluorone,
9-cyano-2,7-di-t-butyl-4,5-diiodo-3-hydroxy-6-fluorone,
7-benzoyl-2,4,5-triiodo-3-hydroxy-6-fluorone,
9-cyano-3-hydroxy-7-butyroyl chloride-6-fluorone.
11. The composition of claim 10 wherein said composition additionally includes an onium salt.
12. The composition of claim 11 wherein said composition includes a diphenyliodonium salt.
13. The composition of claim 5 wherein R10 is acryloyl or methacryloyl.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/154,880 US5451343A (en) | 1991-05-20 | 1993-11-19 | Fluorone and pyronin y derivatives |
PCT/US1994/000695 WO1995014689A1 (en) | 1993-11-19 | 1994-01-18 | Fluorone and pyronin y derivatives |
US08/388,802 US5623080A (en) | 1991-05-20 | 1995-02-15 | Fluorone and pyronin Y derivatives |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70288691A | 1991-05-20 | 1991-05-20 | |
US75661191A | 1991-09-09 | 1991-09-09 | |
US77210391A | 1991-10-07 | 1991-10-07 | |
US88104892A | 1992-05-11 | 1992-05-11 | |
US08/154,880 US5451343A (en) | 1991-05-20 | 1993-11-19 | Fluorone and pyronin y derivatives |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US77210391A Continuation-In-Part | 1991-05-20 | 1991-10-07 | |
US88104892A Continuation-In-Part | 1991-05-20 | 1992-05-11 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/388,802 Division US5623080A (en) | 1991-05-20 | 1995-02-15 | Fluorone and pyronin Y derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
US5451343A true US5451343A (en) | 1995-09-19 |
Family
ID=22553203
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/154,880 Expired - Fee Related US5451343A (en) | 1991-05-20 | 1993-11-19 | Fluorone and pyronin y derivatives |
US08/388,802 Expired - Lifetime US5623080A (en) | 1991-05-20 | 1995-02-15 | Fluorone and pyronin Y derivatives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/388,802 Expired - Lifetime US5623080A (en) | 1991-05-20 | 1995-02-15 | Fluorone and pyronin Y derivatives |
Country Status (2)
Country | Link |
---|---|
US (2) | US5451343A (en) |
WO (1) | WO1995014689A1 (en) |
Cited By (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997016406A1 (en) * | 1995-10-31 | 1997-05-09 | Spectra Group Limited, Inc. | Photosensitive intramolecular electron transfer compounds |
WO1997021737A1 (en) * | 1995-12-14 | 1997-06-19 | Spectra Group Limited, Inc. | Photoinitiator composition containing a borate salt and a hypervalent atom-containing salt |
WO1997039064A1 (en) | 1996-04-12 | 1997-10-23 | Molecular Probes, Inc. | Fluorinated xanthene derivatives |
US5854298A (en) * | 1997-09-29 | 1998-12-29 | Lockheed Martin Corporation | Photocurable low observable aircraft materials |
US5916427A (en) * | 1995-11-08 | 1999-06-29 | Kirkpatrick; Francis H | Methods and reagents for gel electrophoresis |
US5915419A (en) * | 1997-11-26 | 1999-06-29 | Insituform (Netherlands) B.V. | Cured in place lateral seal for relining of pipelines and method of manufacture |
WO1999036191A1 (en) * | 1998-01-20 | 1999-07-22 | Acushnet Company | Ultraviolet and/or visible light curable inks with photoinitiators for game balls, golf balls and the like |
US6029726A (en) * | 1997-11-26 | 2000-02-29 | Insituform (Netherlands) B.V. | Apparatus for installing a flexible cured in place lateral seal in an existing main pipeline |
US6068725A (en) * | 1997-11-26 | 2000-05-30 | Insituform (Netherlands) B.V. | Method of installation of a flexible cured in place lateral seal in an existing main pipeline |
US6130101A (en) * | 1997-09-23 | 2000-10-10 | Molecular Probes, Inc. | Sulfonated xanthene derivatives |
US6150656A (en) * | 1998-12-10 | 2000-11-21 | United Technologies Corporation | Method of assembly and inspection for a gas turbine engine |
US6211262B1 (en) | 1998-04-20 | 2001-04-03 | Spectra Group Limited, Inc. | Corrosion resistant, radiation curable coating |
US6500495B2 (en) | 1997-02-27 | 2002-12-31 | Acushnet Company | Method for curing reactive ink on game balls |
US20030010090A1 (en) * | 1998-12-25 | 2003-01-16 | Nsk Ltd. | Lubricant applying system for a rolling bearing |
WO2003030817A2 (en) | 2001-10-12 | 2003-04-17 | Molecular Probes, Inc. | Antibody complexes and methods for immunolabeling |
US20040038306A1 (en) * | 2002-05-03 | 2004-02-26 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
US20040096978A1 (en) * | 2000-12-20 | 2004-05-20 | Martin Vladimir V. | Crown ether derivatives |
US20040171034A1 (en) * | 2002-05-03 | 2004-09-02 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
US20040259665A1 (en) * | 2003-06-17 | 2004-12-23 | Sullivan Michael J. | Golf ball comprising UV-cured non-surface layer |
US20050014197A1 (en) * | 2002-05-03 | 2005-01-20 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
US20050037332A1 (en) * | 2003-03-28 | 2005-02-17 | Tetsuo Nagano | Fluorescent probe for zinc |
US20050069962A1 (en) * | 2001-10-12 | 2005-03-31 | Archer Robert M | Antibody complexes and methods for immunolabeling |
US20050154081A1 (en) * | 2004-01-09 | 2005-07-14 | Bisco, Inc. | Opacity and color change polymerizable dental materials |
US20050159606A1 (en) * | 2003-10-24 | 2005-07-21 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US20050182253A1 (en) * | 2004-01-09 | 2005-08-18 | Shigenobu Yano | Fluorescent zinc ion sensor |
US20050191643A1 (en) * | 2003-08-11 | 2005-09-01 | Rosaria Haugland | Cyanine compounds and their application as quenching compounds |
US20050277144A1 (en) * | 2001-09-07 | 2005-12-15 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US20060160068A1 (en) * | 2003-09-17 | 2006-07-20 | Joseph Beechem | Competitive immunoassay |
US20060204990A1 (en) * | 2001-09-07 | 2006-09-14 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US20060211122A1 (en) * | 2002-10-16 | 2006-09-21 | Tetsuo Nagano | Reagents for the measurement of peroxynitrites |
US20060252099A1 (en) * | 2000-02-28 | 2006-11-09 | Daiichi Pure Chemicals Co., Ltd. | Method for measurement by using long-lived excitation fluorescence |
US20060252850A1 (en) * | 2005-05-04 | 2006-11-09 | Bausch & Lomb Incorporated | Radiation-absorbing polymeric materials and ophthalmic devices comprising same |
US20070043212A1 (en) * | 2000-12-20 | 2007-02-22 | Molecular Probes, Inc. | Crown ether derivatives |
US20070092830A1 (en) * | 2005-10-24 | 2007-04-26 | Bausch & Lomb Incorporated | Polymeric radiation-absorbing materials and ophthalmic devices comprising same |
US20070092831A1 (en) * | 2005-10-24 | 2007-04-26 | Bausch & Lomb Incorporated | Radiation-absorbing polymeric materials and ophthalmic devices comprising same |
US20070110672A1 (en) * | 2003-12-24 | 2007-05-17 | Bellott Emile M | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
US20070122735A1 (en) * | 2005-11-30 | 2007-05-31 | Wisnudel Marc B | Optical storage device having limited-use content and method for making same |
US20070138411A1 (en) * | 2005-12-19 | 2007-06-21 | Henkel Corporation | Visible light curing systems, methods for reducing health risks to individuals exposed to systems designed to cure curable compositions by exposure to radiation, methods for bonding substrates and visible light curing compositions |
US20070154958A1 (en) * | 2005-10-13 | 2007-07-05 | Aureon Laboratories, Inc. | Multiplex in situ immunohistochemical analysis |
US20070161112A1 (en) * | 2006-01-12 | 2007-07-12 | Invitrogen Corporation | Heavy metal binding compounds and their method of use |
US20070190597A1 (en) * | 2006-02-10 | 2007-08-16 | Invitrogen Corporation | Oligosaccharide modification and labeling of proteins |
US20070187947A1 (en) * | 2004-06-15 | 2007-08-16 | Andreas Heeschen | Binder-free photopolymerizable compositions |
US20070224652A1 (en) * | 2006-03-23 | 2007-09-27 | Jan Holgersson | Blood Group Antigens of Different Types for Diagnostic and Therapeutic Applications |
WO2007124464A2 (en) | 2006-04-20 | 2007-11-01 | Becton, Dickinson And Company | Thermostable proteins and methods of making and using thereof |
US20080009026A1 (en) * | 2006-07-07 | 2008-01-10 | Invitrogen Corporation | Fluorogenic protein kinase substrates |
US20080160627A1 (en) * | 2003-11-19 | 2008-07-03 | Invitrogen Corporation | Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection |
US7446202B2 (en) | 2003-12-05 | 2008-11-04 | Molecular Probes, Inc. | Cyanine dye compounds |
US20090004753A1 (en) * | 2007-01-30 | 2009-01-01 | Invitrogen Corporation | Labeling reagents and methods of their use |
US20090030106A1 (en) * | 2007-07-23 | 2009-01-29 | Henkel Corporation | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same |
EP2022464A2 (en) | 2007-08-07 | 2009-02-11 | Kerr Corporation | Gingival retraction with light curable composition |
US20090081722A1 (en) * | 2002-09-12 | 2009-03-26 | Invitrogen Corporation | Site-specific labeling of affinity tags in fusion proteins |
US7582461B2 (en) | 2003-07-29 | 2009-09-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US20090246441A1 (en) * | 2008-03-31 | 2009-10-01 | Nbc Universal, Inc. | System and Method for Photobleaching of Optical Media |
US20090247984A1 (en) * | 2007-10-24 | 2009-10-01 | Masimo Laboratories, Inc. | Use of microneedles for small molecule metabolite reporter delivery |
US7598390B2 (en) | 2005-05-11 | 2009-10-06 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
US20090263612A1 (en) * | 2008-04-18 | 2009-10-22 | Nbc Universal, Inc. | System and Method for Photobleaching of Optical Media |
US7619059B2 (en) | 2003-07-29 | 2009-11-17 | Life Technologies Corporation | Bimolecular optical probes |
US20100009342A1 (en) * | 2005-09-06 | 2010-01-14 | Life Technologies Corporation | Control of chemical modification |
US20100112458A1 (en) * | 2004-06-22 | 2010-05-06 | Xetos Ag | Photopolymerisable composition |
US7714037B1 (en) | 2006-12-15 | 2010-05-11 | Henkel Corporation | Photoinitiated cationic epoxy compositions and articles exhibiting low color |
US20100118674A1 (en) * | 2008-11-13 | 2010-05-13 | General Electric Company | System and method for combining pre-mastered errors with marks or printed spots on optical media |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US20100167320A1 (en) * | 2006-01-30 | 2010-07-01 | Life Technologies Corporation | Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States |
US20100203564A1 (en) * | 2007-05-30 | 2010-08-12 | Life Technologies Corporation | Fluorescent Phospholipase A2 Indicators |
US7776529B2 (en) | 2003-12-05 | 2010-08-17 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
EP2224013A1 (en) | 2007-02-13 | 2010-09-01 | Life Technologies Corporation | Methods for the determination of telomerase activity using click chemistry |
WO2010099137A2 (en) | 2009-02-26 | 2010-09-02 | Osi Pharmaceuticals, Inc. | In situ methods for monitoring the emt status of tumor cells in vivo |
US20100248190A1 (en) * | 2007-08-07 | 2010-09-30 | Kerr Corporation | Method of using dental composition |
US20100255601A1 (en) * | 2006-01-24 | 2010-10-07 | Invitrogen Corporation | Device and methods for quantifying analytes |
US20110118142A1 (en) * | 2008-05-16 | 2011-05-19 | Life Technologies Corporation | Dual labeling methods for measuring cellular proliferation |
US20110159517A1 (en) * | 2003-05-05 | 2011-06-30 | Life Technologies Corporation | Zinc binding compounds and their method of use |
EP2368954A1 (en) | 2005-06-21 | 2011-09-28 | Henkel Corporation | Photocurable elastomer composition |
US8030401B1 (en) | 2006-08-03 | 2011-10-04 | Henkel Corporation | Photoinitiated cationic epoxy compositions |
WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
EP2450024A2 (en) | 2010-11-04 | 2012-05-09 | Kerr Corporation | Dental material with color indicator and metods of using same |
US8318450B2 (en) | 2004-01-21 | 2012-11-27 | Life Technologies Corporation | Optically-detectable enzyme substrates and their method of use |
WO2013036502A1 (en) | 2011-09-07 | 2013-03-14 | Microchem Corp. | Epoxy formulations and processes for fabrication of relief patterns on low surface energy substrates |
US8488428B2 (en) | 2008-05-14 | 2013-07-16 | Nbcuniversal Media, Llc | Enhanced security of optical article |
US8562802B1 (en) | 2006-02-13 | 2013-10-22 | Life Technologies Corporation | Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems |
WO2014066733A2 (en) | 2012-10-25 | 2014-05-01 | Life Technologies Corporation | Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins |
EP2727965A1 (en) | 2006-10-27 | 2014-05-07 | Life Technologies Corporation | Fluorogenic pH sensitive dyes and their method of use |
US8974651B2 (en) | 2010-04-17 | 2015-03-10 | C.C. Imex | Illuminator for visualization of fluorophores |
WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
US9372181B2 (en) | 2004-07-27 | 2016-06-21 | Life Technologies Corporation | Fluorescent metal ion indicators with large stokes shifts |
WO2016111915A1 (en) | 2015-01-06 | 2016-07-14 | De Haas Anthony H | Near-infrared fluorescent surgical dye markers |
US9399004B2 (en) | 2010-11-04 | 2016-07-26 | Kerr Corporation | Dental composition having a redox indicator and method of using same |
US9504405B2 (en) | 2013-10-23 | 2016-11-29 | Verily Life Sciences Llc | Spatial modulation of magnetic particles in vasculature by external magnetic field |
US9522099B2 (en) | 2010-11-04 | 2016-12-20 | Kerr Corporation | Dental compositions having special functionality and a tri-barrel packaging and delivery system therefor |
WO2017181176A1 (en) | 2016-04-15 | 2017-10-19 | Lcahn School Of Medicine At Mount Sinai | Tissue profiling using multiplexed immunohistochemical consecutive staining |
US9835587B2 (en) | 2014-04-01 | 2017-12-05 | C.C. Imex | Electrophoresis running tank assembly |
US9861710B1 (en) | 2015-01-16 | 2018-01-09 | Verily Life Sciences Llc | Composite particles, methods, and in vivo diagnostic system |
US10017659B1 (en) | 2017-10-09 | 2018-07-10 | Delphi Technologies, Inc | Robust sealed electric terminal assembly |
US10028659B2 (en) | 2015-03-26 | 2018-07-24 | Verily Life Sciences Llc | Aptamer-based sensors, implantable devices and detection system |
US20180278004A1 (en) * | 2017-03-27 | 2018-09-27 | Delphi Technologies, Inc. | Sealed electric terminal assembly and method |
WO2018183621A1 (en) | 2017-03-30 | 2018-10-04 | Life Technologies Corporation | Quantification of ngs dna by adapter sequence |
US10307940B2 (en) | 2016-05-13 | 2019-06-04 | MSI Coatings Inc. | System and method for using a VOC free low radiant flux LED UV curable composition |
US10542918B2 (en) | 2013-10-23 | 2020-01-28 | Verily Life Sciences Llc | Modulation of a response signal to distinguish between analyte and background signals |
US10574014B2 (en) | 2017-03-27 | 2020-02-25 | Aptiv Technologies Limited | Method for sealing electric terminal assembly |
US10815388B2 (en) | 2013-05-30 | 2020-10-27 | Henkel IP & Holding GmbH | Primer compositions for injection molding |
EP3733244A1 (en) | 2013-10-02 | 2020-11-04 | Medlmmune, LLC | Neutralizing anti-influenza a antibodies and uses thereof |
WO2022006368A2 (en) | 2020-07-02 | 2022-01-06 | Life Technologies Corporation | Trinucleotide cap analogs, preparation and uses thereof |
US11338320B1 (en) | 2018-02-03 | 2022-05-24 | MSI Coatings Inc. | Composition for aerosol cans, method of making and using the same |
WO2023004400A1 (en) | 2021-07-21 | 2023-01-26 | Life Technologies Corporation | Dibenzoxanthene quenchers, uses, and methods of preparation |
US11635688B2 (en) | 2012-03-08 | 2023-04-25 | Kayaku Advanced Materials, Inc. | Photoimageable compositions and processes for fabrication of relief patterns on low surface energy substrates |
US11697740B2 (en) | 2015-09-28 | 2023-07-11 | Henkel Ag & Co. Kgaa | Primer compositions for injection molding |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6229024B1 (en) * | 1998-01-23 | 2001-05-08 | Laurence C. Schmued | Method for detecting neuronal degeneration and anionic fluorescein homologue stains therefor |
EP1260508B1 (en) | 2000-02-29 | 2010-04-14 | Sekisui Medical Co., Ltd. | Reagents for the quantitation of active oxygen |
US20040054195A1 (en) * | 2002-01-10 | 2004-03-18 | Jianxin Gao | Xanthene derivatives |
JP4206378B2 (en) * | 2002-07-08 | 2009-01-07 | 哲雄 長野 | Fluorescent probe |
US7378282B2 (en) * | 2003-05-14 | 2008-05-27 | Tetsuo Nagano | Method for measuring hypochlorite ion |
AU2004277378A1 (en) * | 2003-08-01 | 2005-04-14 | Glotell Products, Inc. | Dye solution and method for detecting anhydrous ammonia |
EP2393805B1 (en) | 2009-02-03 | 2015-08-26 | Biotium Inc. | Xanthene dyes comprising a sulfonamide group |
US9579402B2 (en) * | 2009-12-04 | 2017-02-28 | Biotium, Inc. | Heterocycle-substituted xanthene dyes |
CN102952109A (en) * | 2011-08-11 | 2013-03-06 | 住友化学株式会社 | Compound used in color composition |
US9754084B2 (en) | 2012-10-02 | 2017-09-05 | Covestro Deutschland Ag | Method for selecting photoinitiator systems |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1885592A (en) * | 1929-06-29 | 1932-11-01 | Ici Ltd | Process for the manufacture of new xanthene dyes |
US2157351A (en) * | 1934-12-28 | 1939-05-09 | Agfa Ansco Corp | Sensitizing dyes for photographic emulsions |
US2875047A (en) * | 1955-01-19 | 1959-02-24 | Oster Gerald | Photopolymerization with the formation of coherent plastic masses |
GB1058516A (en) * | 1965-06-21 | 1967-02-15 | Centre Nat Rech Scient | Contrast agent for medical use |
GB1123767A (en) * | 1965-07-20 | 1968-08-14 | Basf Ag | Dyeing or printing polyacrylonitrile textile material |
US4329461A (en) * | 1980-01-11 | 1982-05-11 | Syva Company | Fluorescent thyroid hormone conjugates and their uses |
JPS59176641A (en) * | 1983-03-28 | 1984-10-06 | Idemitsu Kosan Co Ltd | Hydraulic oil |
US4481136A (en) * | 1979-09-07 | 1984-11-06 | Syva Company | Alkyl substituted fluorescent compounds and conjugates |
US4492762A (en) * | 1981-12-11 | 1985-01-08 | Abbott Laboratories | Fluorescent polarization immunoassays |
US4552830A (en) * | 1978-05-09 | 1985-11-12 | Dynachem Corporation | Carbonylic halides as activators for phototropic compositions |
US4585862A (en) * | 1981-12-11 | 1986-04-29 | Abbott Laboratories | Fluorescence polarization immunoassay |
US4647675A (en) * | 1984-07-12 | 1987-03-03 | Basf Aktiengesellschaft | Rhodamine dyes |
US4716097A (en) * | 1986-02-03 | 1987-12-29 | E. I. Du Pont De Nemours And Company | Increased photopolymer photospeed employing yellow light preexposure |
US4772530A (en) * | 1986-05-06 | 1988-09-20 | The Mead Corporation | Photosensitive materials containing ionic dye compounds as initiators |
WO1990010254A1 (en) * | 1989-02-24 | 1990-09-07 | Bowling Green State University | Production of three dimensional bodies by photopolymerization |
US5096530A (en) * | 1990-06-28 | 1992-03-17 | 3D Systems, Inc. | Resin film recoating method and apparatus |
US5100928A (en) * | 1990-04-18 | 1992-03-31 | Olin Corporation | Compositions containing organic-soluble xanthene dye photoinitiators |
US5137890A (en) * | 1990-02-14 | 1992-08-11 | Ortho Pharmaceutical Corporation | 4-phenyl tetrahydropyrido(4,3-d)pyrimidines |
EP0507493A1 (en) * | 1991-03-27 | 1992-10-07 | General Electric Company | Epoxy-functional fluorosilicones |
EP0530095A1 (en) * | 1991-08-26 | 1993-03-03 | Minnesota Mining And Manufacturing Company | Improved sensitization of photopolymerizable compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4883750A (en) * | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4855225A (en) * | 1986-02-07 | 1989-08-08 | Applied Biosystems, Inc. | Method of detecting electrophoretically separated oligonucleotides |
US4852017A (en) * | 1987-06-19 | 1989-07-25 | Applied Biosystems, Inc. | Determination of peptide sequences |
US5093245A (en) * | 1988-01-26 | 1992-03-03 | Applied Biosystems | Labeling by simultaneous ligation and restriction |
US5137800A (en) * | 1989-02-24 | 1992-08-11 | Stereographics Limited Partnership | Production of three dimensional bodies by photopolymerization |
-
1993
- 1993-11-19 US US08/154,880 patent/US5451343A/en not_active Expired - Fee Related
-
1994
- 1994-01-18 WO PCT/US1994/000695 patent/WO1995014689A1/en active Application Filing
-
1995
- 1995-02-15 US US08/388,802 patent/US5623080A/en not_active Expired - Lifetime
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1885592A (en) * | 1929-06-29 | 1932-11-01 | Ici Ltd | Process for the manufacture of new xanthene dyes |
US2157351A (en) * | 1934-12-28 | 1939-05-09 | Agfa Ansco Corp | Sensitizing dyes for photographic emulsions |
US2875047A (en) * | 1955-01-19 | 1959-02-24 | Oster Gerald | Photopolymerization with the formation of coherent plastic masses |
GB1058516A (en) * | 1965-06-21 | 1967-02-15 | Centre Nat Rech Scient | Contrast agent for medical use |
GB1123767A (en) * | 1965-07-20 | 1968-08-14 | Basf Ag | Dyeing or printing polyacrylonitrile textile material |
US4552830A (en) * | 1978-05-09 | 1985-11-12 | Dynachem Corporation | Carbonylic halides as activators for phototropic compositions |
US4481136A (en) * | 1979-09-07 | 1984-11-06 | Syva Company | Alkyl substituted fluorescent compounds and conjugates |
US4329461A (en) * | 1980-01-11 | 1982-05-11 | Syva Company | Fluorescent thyroid hormone conjugates and their uses |
US4585862A (en) * | 1981-12-11 | 1986-04-29 | Abbott Laboratories | Fluorescence polarization immunoassay |
US4492762A (en) * | 1981-12-11 | 1985-01-08 | Abbott Laboratories | Fluorescent polarization immunoassays |
US4492762B1 (en) * | 1981-12-11 | 1991-08-13 | Abbott Lab | |
JPS59176641A (en) * | 1983-03-28 | 1984-10-06 | Idemitsu Kosan Co Ltd | Hydraulic oil |
US4647675A (en) * | 1984-07-12 | 1987-03-03 | Basf Aktiengesellschaft | Rhodamine dyes |
US4716097A (en) * | 1986-02-03 | 1987-12-29 | E. I. Du Pont De Nemours And Company | Increased photopolymer photospeed employing yellow light preexposure |
US4772530A (en) * | 1986-05-06 | 1988-09-20 | The Mead Corporation | Photosensitive materials containing ionic dye compounds as initiators |
WO1990010254A1 (en) * | 1989-02-24 | 1990-09-07 | Bowling Green State University | Production of three dimensional bodies by photopolymerization |
US5137890A (en) * | 1990-02-14 | 1992-08-11 | Ortho Pharmaceutical Corporation | 4-phenyl tetrahydropyrido(4,3-d)pyrimidines |
US5100928A (en) * | 1990-04-18 | 1992-03-31 | Olin Corporation | Compositions containing organic-soluble xanthene dye photoinitiators |
US5096530A (en) * | 1990-06-28 | 1992-03-17 | 3D Systems, Inc. | Resin film recoating method and apparatus |
EP0507493A1 (en) * | 1991-03-27 | 1992-10-07 | General Electric Company | Epoxy-functional fluorosilicones |
EP0530095A1 (en) * | 1991-08-26 | 1993-03-03 | Minnesota Mining And Manufacturing Company | Improved sensitization of photopolymerizable compositions |
Non-Patent Citations (20)
Title |
---|
Amt Guerri et al., Singlet Oxygen Photogeneration . . . , Photochem. and Photobio. 53:199 210 (1990). * |
Amt Guerri et al., Synthesis and Spectroscopic Properties . . . , Chem. Abs. 112:236887b. * |
Amt-Guerri et al., "Singlet Oxygen Photogeneration . . . ", Photochem. and Photobio. 53:199-210 (1990). |
Amt-Guerri et al., "Synthesis and Spectroscopic Properties . . . ", Chem. Abs. 112:236887b. |
CA105: 80656t, Novel Radical Couplings . . . , Phillips, et al. PCT International Search Report mailed Jun. 3, 1994. * |
CA107(25): 228304r, "The Raising and Characterization . . . " Bennett, et al. |
CA107(25): 228304r, The Raising and Characterization . . . Bennett, et al. * |
Flossman et al., Mechanism of the color reaction of DNA . . . , Chem. Abs. 76:46433r. * |
Hobbs et al., Preparation of (aminoalkynyl) nucleotides . . ., Chem. Abs. 109:93540h. * |
J. Org. Chem., vol. 57, "Xanthenes: Fluorone Derivatives . . . " Shi, et al. |
J. Org. Chem., vol. 57, Xanthenes: Fluorone Derivatives . . . Shi, et al. * |
Janjie et al., "Multiligand Interactions . . . ," JACS 111:6374-6377 (1989). |
Janjie et al., Multiligand Interactions . . . , JACS 111:6374 6377 (1989). * |
Phillips and Read, "Novel Radical Couplings . . . ," J. Chem. Soc., 671-73 (1986). |
Phillips and Read, Novel Radical Couplings . . . , J. Chem. Soc., 671 73 (1986). * |
Shapovalov, "Study of spectral and acid-base properties . . . ," Chem. Abs. 101:56476f. |
Shapovalov, Study of spectral and acid base properties . . . , Chem. Abs. 101:56476f. * |
Shen, "A study on 6-hydroxyfluorone . . . ," Chem. Abs. 107:156351d. |
Shen, A study on 6 hydroxyfluorone . . . , Chem. Abs. 107:156351d. * |
Wang et al., Study on a new chromogenic reagent . . . , Chem. Abs. 115:246974d. * |
Cited By (217)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998496A (en) * | 1995-10-31 | 1999-12-07 | Spectra Group Limited, Inc. | Photosensitive intramolecular electron transfer compounds |
WO1997016406A1 (en) * | 1995-10-31 | 1997-05-09 | Spectra Group Limited, Inc. | Photosensitive intramolecular electron transfer compounds |
US5916427A (en) * | 1995-11-08 | 1999-06-29 | Kirkpatrick; Francis H | Methods and reagents for gel electrophoresis |
WO1997021737A1 (en) * | 1995-12-14 | 1997-06-19 | Spectra Group Limited, Inc. | Photoinitiator composition containing a borate salt and a hypervalent atom-containing salt |
EP0853647B1 (en) * | 1996-04-12 | 2004-10-13 | Molecular Probes, Inc. | Fluorinated xanthene derivatives |
WO1997039064A1 (en) | 1996-04-12 | 1997-10-23 | Molecular Probes, Inc. | Fluorinated xanthene derivatives |
US6162931A (en) * | 1996-04-12 | 2000-12-19 | Molecular Probes, Inc. | Fluorinated xanthene derivatives |
US6229055B1 (en) | 1996-04-12 | 2001-05-08 | Molecular Probes, Inc. | Synthesis of fluorinated xanthene derivatives |
US6248804B1 (en) | 1997-02-27 | 2001-06-19 | Acushnet Company | Ultraviolet and or/ visible light curable inks with photoinitiators for game balls, golf balls and the like |
US6500495B2 (en) | 1997-02-27 | 2002-12-31 | Acushnet Company | Method for curing reactive ink on game balls |
US6130101A (en) * | 1997-09-23 | 2000-10-10 | Molecular Probes, Inc. | Sulfonated xanthene derivatives |
US5854298A (en) * | 1997-09-29 | 1998-12-29 | Lockheed Martin Corporation | Photocurable low observable aircraft materials |
US5915419A (en) * | 1997-11-26 | 1999-06-29 | Insituform (Netherlands) B.V. | Cured in place lateral seal for relining of pipelines and method of manufacture |
US6029726A (en) * | 1997-11-26 | 2000-02-29 | Insituform (Netherlands) B.V. | Apparatus for installing a flexible cured in place lateral seal in an existing main pipeline |
US6044867A (en) * | 1997-11-26 | 2000-04-04 | Insituform (Netherlands) N.V. | Method and apparatus for fabricating a flexible lining with flexible collar for lining lateral pipelines |
US6068725A (en) * | 1997-11-26 | 2000-05-30 | Insituform (Netherlands) B.V. | Method of installation of a flexible cured in place lateral seal in an existing main pipeline |
US6520719B1 (en) | 1997-11-26 | 2003-02-18 | Insituform (Netherlands) B.V. | Apparatus for installing a flexible cured in place lateral seal in an existing main pipeline |
WO1999036191A1 (en) * | 1998-01-20 | 1999-07-22 | Acushnet Company | Ultraviolet and/or visible light curable inks with photoinitiators for game balls, golf balls and the like |
GB2348647A (en) * | 1998-01-20 | 2000-10-11 | Acushnet Co | Ultraviolet and/or visible light curable inks with photoinitiators for game balls golf balls and the like |
US6211262B1 (en) | 1998-04-20 | 2001-04-03 | Spectra Group Limited, Inc. | Corrosion resistant, radiation curable coating |
US6150656A (en) * | 1998-12-10 | 2000-11-21 | United Technologies Corporation | Method of assembly and inspection for a gas turbine engine |
US20030010090A1 (en) * | 1998-12-25 | 2003-01-16 | Nsk Ltd. | Lubricant applying system for a rolling bearing |
US6898959B2 (en) | 1998-12-25 | 2005-05-31 | Nsk Ltd. | Lubricant applying system for a rolling bearing |
US20040211241A1 (en) * | 1998-12-25 | 2004-10-28 | Nsk Ltd. | Lubricant applying system for a rolling bearing |
US6755071B2 (en) * | 1998-12-25 | 2004-06-29 | Nsk, Ltd. | Lubricant applying system for a rolling bearing |
US20060252099A1 (en) * | 2000-02-28 | 2006-11-09 | Daiichi Pure Chemicals Co., Ltd. | Method for measurement by using long-lived excitation fluorescence |
US20070043212A1 (en) * | 2000-12-20 | 2007-02-22 | Molecular Probes, Inc. | Crown ether derivatives |
US7989617B2 (en) | 2000-12-20 | 2011-08-02 | Life Technologies Corporation | Crown ether derivatives |
US20040096978A1 (en) * | 2000-12-20 | 2004-05-20 | Martin Vladimir V. | Crown ether derivatives |
US7579463B2 (en) | 2000-12-20 | 2009-08-25 | Life Technologies Corporation | Crown ether derivatives |
US7129346B2 (en) | 2000-12-20 | 2006-10-31 | Molecular Probes, Inc. | Crown ether derivatives |
US8569516B2 (en) | 2001-09-07 | 2013-10-29 | Elitech Holding B.V. | Compounds and methods for fluorescent labeling |
US7601851B2 (en) * | 2001-09-07 | 2009-10-13 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US20060204990A1 (en) * | 2001-09-07 | 2006-09-14 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US20050277144A1 (en) * | 2001-09-07 | 2005-12-15 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US8304195B2 (en) | 2001-10-12 | 2012-11-06 | Life Technologies Corporation | Antibody complexes and methods for immunolabeling |
US8535894B2 (en) | 2001-10-12 | 2013-09-17 | Life Technologies Corporation | Antibody complexes and methods for immunolabeling |
US8323903B2 (en) | 2001-10-12 | 2012-12-04 | Life Technologies Corporation | Antibody complexes and methods for immunolabeling |
EP2113773A2 (en) | 2001-10-12 | 2009-11-04 | Molecular Probes, Inc. | Antibody complexes and methods for immunolabeling |
US20090124511A1 (en) * | 2001-10-12 | 2009-05-14 | Invitrogen Corporation | Antibody complexes and methods for immunolabeling |
WO2003030817A2 (en) | 2001-10-12 | 2003-04-17 | Molecular Probes, Inc. | Antibody complexes and methods for immunolabeling |
US20070269902A1 (en) * | 2001-10-12 | 2007-11-22 | Joseph Beechem | Antibody complexes and methods for immunolabeling |
EP2259067A2 (en) | 2001-10-12 | 2010-12-08 | Molecular Probes, Inc. | Methods for immunolabeling |
US20050069962A1 (en) * | 2001-10-12 | 2005-03-31 | Archer Robert M | Antibody complexes and methods for immunolabeling |
US20030073149A1 (en) * | 2001-10-12 | 2003-04-17 | Archer Robert A. | Antibody complexes and methods for immunolabeling |
US20040171034A1 (en) * | 2002-05-03 | 2004-09-02 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
US20040038306A1 (en) * | 2002-05-03 | 2004-02-26 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
US20070054304A1 (en) * | 2002-05-03 | 2007-03-08 | Invitrogen Corporation | Compositions and methods for detection and isolation of phosphorylated molecules |
US7102005B2 (en) | 2002-05-03 | 2006-09-05 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
US7776533B2 (en) | 2002-05-03 | 2010-08-17 | Life Technologies Corporation | Compositions and methods for detection and isolation of phosphorylated molecules |
US7445894B2 (en) | 2002-05-03 | 2008-11-04 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
US20050014197A1 (en) * | 2002-05-03 | 2005-01-20 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
US20090081722A1 (en) * | 2002-09-12 | 2009-03-26 | Invitrogen Corporation | Site-specific labeling of affinity tags in fusion proteins |
US9164099B2 (en) | 2002-09-12 | 2015-10-20 | Life Technologies Corporation | Site-specific labeling of affinity tags in fusion proteins |
US20060211122A1 (en) * | 2002-10-16 | 2006-09-21 | Tetsuo Nagano | Reagents for the measurement of peroxynitrites |
US20050037332A1 (en) * | 2003-03-28 | 2005-02-17 | Tetsuo Nagano | Fluorescent probe for zinc |
US7696245B2 (en) | 2003-03-28 | 2010-04-13 | Sekisui Medical Co., Ltd. | Fluorescent probe for zinc |
US8445702B2 (en) | 2003-05-05 | 2013-05-21 | Life Technologies Corporation | Zinc binding compounds and their method of use |
US20110159517A1 (en) * | 2003-05-05 | 2011-06-30 | Life Technologies Corporation | Zinc binding compounds and their method of use |
US20070082754A1 (en) * | 2003-06-17 | 2007-04-12 | Acushnet Company | Golf ball comprising UV-cured non-surface layer |
US7198576B2 (en) | 2003-06-17 | 2007-04-03 | Acushnet Company | Golf ball comprising UV-cured non-surface layer |
US20040259665A1 (en) * | 2003-06-17 | 2004-12-23 | Sullivan Michael J. | Golf ball comprising UV-cured non-surface layer |
US8025592B2 (en) | 2003-06-17 | 2011-09-27 | Acushnet Company | Golf ball comprising UV-cured non-surface layer |
US7582461B2 (en) | 2003-07-29 | 2009-09-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US7619059B2 (en) | 2003-07-29 | 2009-11-17 | Life Technologies Corporation | Bimolecular optical probes |
US8067536B2 (en) | 2003-07-29 | 2011-11-29 | Life Technologies Corporation | Kinase and phosphatase assays |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US20080039630A1 (en) * | 2003-08-11 | 2008-02-14 | Invitrogen Corporation | Cyanine compounds and their application as quenching compounds |
US7271265B2 (en) | 2003-08-11 | 2007-09-18 | Invitrogen Corporation | Cyanine compounds and their application as quenching compounds |
US9150922B2 (en) | 2003-08-11 | 2015-10-06 | Life Technologies Corporation | Cyanine compounds and their application as quenching compounds |
US20050191643A1 (en) * | 2003-08-11 | 2005-09-01 | Rosaria Haugland | Cyanine compounds and their application as quenching compounds |
US20110105362A1 (en) * | 2003-08-11 | 2011-05-05 | Life Technologies Corporation | Cyanine compounds and their application as quenching compounds |
US7282339B2 (en) | 2003-09-17 | 2007-10-16 | Invitrogen Corporation | Competitive immunoassay |
US20060160068A1 (en) * | 2003-09-17 | 2006-07-20 | Joseph Beechem | Competitive immunoassay |
US20050159606A1 (en) * | 2003-10-24 | 2005-07-21 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US7541454B2 (en) * | 2003-10-24 | 2009-06-02 | Epoch Biosciences, Inc. | Compounds and methods for fluorescent labeling |
US20080160627A1 (en) * | 2003-11-19 | 2008-07-03 | Invitrogen Corporation | Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection |
US8173698B2 (en) | 2003-11-19 | 2012-05-08 | Life Technologies Corporation | Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection |
US7446202B2 (en) | 2003-12-05 | 2008-11-04 | Molecular Probes, Inc. | Cyanine dye compounds |
US7655409B2 (en) | 2003-12-05 | 2010-02-02 | Life Technologies Corporation | Cyanine dye compounds |
US8470529B2 (en) | 2003-12-05 | 2013-06-25 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
US9403985B2 (en) | 2003-12-05 | 2016-08-02 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
US9040561B2 (en) | 2003-12-05 | 2015-05-26 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
US20090047683A1 (en) * | 2003-12-05 | 2009-02-19 | Invitrogen Corporation | Cyanine dye compounds |
US20100120051A1 (en) * | 2003-12-05 | 2010-05-13 | Life Technologies Corporation | Cyanine dye compounds |
US7842811B2 (en) | 2003-12-05 | 2010-11-30 | Life Technologies Corporation | Cyanine dye compounds |
US7776529B2 (en) | 2003-12-05 | 2010-08-17 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
US10005908B2 (en) | 2003-12-05 | 2018-06-26 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
US20090004108A1 (en) * | 2003-12-24 | 2009-01-01 | Masimo Laboratories, Inc. | Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors |
US20070110672A1 (en) * | 2003-12-24 | 2007-05-17 | Bellott Emile M | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
US8466286B2 (en) | 2003-12-24 | 2013-06-18 | Cercacor Laboratories, Inc. | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
US8029765B2 (en) | 2003-12-24 | 2011-10-04 | Masimo Laboratories, Inc. | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
US8008088B2 (en) * | 2003-12-24 | 2011-08-30 | Masimo Laboratories, Inc. | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
US20050182253A1 (en) * | 2004-01-09 | 2005-08-18 | Shigenobu Yano | Fluorescent zinc ion sensor |
US7541467B2 (en) | 2004-01-09 | 2009-06-02 | Shigenobu Yano | Fluorescent zinc ion sensor |
US20050154081A1 (en) * | 2004-01-09 | 2005-07-14 | Bisco, Inc. | Opacity and color change polymerizable dental materials |
US8865891B2 (en) | 2004-01-21 | 2014-10-21 | Life Technologies Corporation | Optically-detectable enzyme substrates and their method of use |
US8318450B2 (en) | 2004-01-21 | 2012-11-27 | Life Technologies Corporation | Optically-detectable enzyme substrates and their method of use |
US20070187947A1 (en) * | 2004-06-15 | 2007-08-16 | Andreas Heeschen | Binder-free photopolymerizable compositions |
US8603730B2 (en) | 2004-06-22 | 2013-12-10 | Xetos Ag | Photopolymerisable composition |
US20100112458A1 (en) * | 2004-06-22 | 2010-05-06 | Xetos Ag | Photopolymerisable composition |
US9846168B2 (en) | 2004-07-27 | 2017-12-19 | Life Technologies Corporation | Fluorescent metal ion indicators with large stokes shifts |
US9372181B2 (en) | 2004-07-27 | 2016-06-21 | Life Technologies Corporation | Fluorescent metal ion indicators with large stokes shifts |
US20060252850A1 (en) * | 2005-05-04 | 2006-11-09 | Bausch & Lomb Incorporated | Radiation-absorbing polymeric materials and ophthalmic devices comprising same |
US9366676B2 (en) | 2005-05-11 | 2016-06-14 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
US7943777B2 (en) | 2005-05-11 | 2011-05-17 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
US9115397B2 (en) | 2005-05-11 | 2015-08-25 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
US8865904B2 (en) | 2005-05-11 | 2014-10-21 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
US7598390B2 (en) | 2005-05-11 | 2009-10-06 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
EP2368954A1 (en) | 2005-06-21 | 2011-09-28 | Henkel Corporation | Photocurable elastomer composition |
US20100009342A1 (en) * | 2005-09-06 | 2010-01-14 | Life Technologies Corporation | Control of chemical modification |
US20070154958A1 (en) * | 2005-10-13 | 2007-07-05 | Aureon Laboratories, Inc. | Multiplex in situ immunohistochemical analysis |
US8093012B2 (en) | 2005-10-13 | 2012-01-10 | Aureon Laboratories, Inc. | Multiplex in situ immunohistochemical analysis |
US20070092831A1 (en) * | 2005-10-24 | 2007-04-26 | Bausch & Lomb Incorporated | Radiation-absorbing polymeric materials and ophthalmic devices comprising same |
US20070092830A1 (en) * | 2005-10-24 | 2007-04-26 | Bausch & Lomb Incorporated | Polymeric radiation-absorbing materials and ophthalmic devices comprising same |
WO2007064526A2 (en) * | 2005-11-30 | 2007-06-07 | General Electric Company | Optical storage device having limited-use content and method for making same |
WO2007064526A3 (en) * | 2005-11-30 | 2007-08-09 | Gen Electric | Optical storage device having limited-use content and method for making same |
GB2449186A (en) * | 2005-11-30 | 2008-11-12 | Gen Electric | Optical storage device having limited-use content and method for making same |
GB2449186B (en) * | 2005-11-30 | 2010-06-09 | Gen Electric | Optical storage device having limited-use content and method for making same |
US20070122735A1 (en) * | 2005-11-30 | 2007-05-31 | Wisnudel Marc B | Optical storage device having limited-use content and method for making same |
US20070138411A1 (en) * | 2005-12-19 | 2007-06-21 | Henkel Corporation | Visible light curing systems, methods for reducing health risks to individuals exposed to systems designed to cure curable compositions by exposure to radiation, methods for bonding substrates and visible light curing compositions |
US7915319B2 (en) | 2005-12-19 | 2011-03-29 | Henkel Corporation | Visible light curing systems, methods for reducing health risks to individuals exposed to systems designed to cure curable compositions by exposure to radiation, methods for bonding substrates and visible light curing compositions |
US7521577B2 (en) | 2006-01-12 | 2009-04-21 | Molecular Probes, Inc. | Heavy metal binding compounds and their method of use |
US8680320B2 (en) | 2006-01-12 | 2014-03-25 | Life Technologies Corporation | Heavy metal binding compounds and their method of use |
US20070161112A1 (en) * | 2006-01-12 | 2007-07-12 | Invitrogen Corporation | Heavy metal binding compounds and their method of use |
US11635383B2 (en) | 2006-01-24 | 2023-04-25 | Life Technologies Corporation | Device and methods for quantifying analytes introduction |
US9964490B2 (en) | 2006-01-24 | 2018-05-08 | Life Technologies Corporation | Device and methods for quantifying analytes |
US10533946B2 (en) | 2006-01-24 | 2020-01-14 | Life Technologies Corporation | Device and methods for quantifying analytes |
US8551408B2 (en) | 2006-01-24 | 2013-10-08 | Life Technologies Corporation | Device and methods for quantifying analytes |
US8623282B2 (en) | 2006-01-24 | 2014-01-07 | Life Technologies Corporation | Device and methods for quantifying analytes |
US20100255601A1 (en) * | 2006-01-24 | 2010-10-07 | Invitrogen Corporation | Device and methods for quantifying analytes |
US10962480B2 (en) | 2006-01-24 | 2021-03-30 | Life Technologies Corporation | Device and methods for quantifying analytes introduction |
US20100167320A1 (en) * | 2006-01-30 | 2010-07-01 | Life Technologies Corporation | Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States |
EP4092418A1 (en) | 2006-02-10 | 2022-11-23 | Life Technologies Corporation | Oligosaccharide modification and labeling of proteins |
EP2623610A2 (en) | 2006-02-10 | 2013-08-07 | Life Technologies Corporation | Labeling and detection of post translationally modified proteins |
US9645140B2 (en) | 2006-02-10 | 2017-05-09 | Life Technologies Corporation | Labeling and detection of post translationally modified proteins |
US20110207171A1 (en) * | 2006-02-10 | 2011-08-25 | Life Technologies Corporation | Oligosaccharide modification and labeling of proteins |
US8785212B2 (en) | 2006-02-10 | 2014-07-22 | Life Technologies Corporation | Oligosaccharide modification and labeling of proteins |
US8716033B2 (en) | 2006-02-10 | 2014-05-06 | Life Technologies Corporation | Oligosaccharide modification and labeling of proteins |
EP3438131A1 (en) | 2006-02-10 | 2019-02-06 | Life Technologies Corporation | Oligosaccharide modification and labeling of proteins |
US20070249014A1 (en) * | 2006-02-10 | 2007-10-25 | Invitrogen Corporation | Labeling and detection of post translationally modified proteins |
US20070190597A1 (en) * | 2006-02-10 | 2007-08-16 | Invitrogen Corporation | Oligosaccharide modification and labeling of proteins |
US10676771B2 (en) | 2006-02-10 | 2020-06-09 | Life Technologies Corporation | Oligosaccharide modification and labeling of proteins |
EP2623986A2 (en) | 2006-02-10 | 2013-08-07 | Life Technologies Corporation | Labeling and detection of post translationally modified proteins |
EP2623609A2 (en) | 2006-02-10 | 2013-08-07 | Life Technologies Corporation | Labeling and detection of post translationally modified proteins |
US8562802B1 (en) | 2006-02-13 | 2013-10-22 | Life Technologies Corporation | Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems |
EP2362223A2 (en) | 2006-03-23 | 2011-08-31 | Absorber AB | Blood group antigens of different types for diagnostic and therapeutic applications |
EP2362224A2 (en) | 2006-03-23 | 2011-08-31 | Absorber AB | Blood group antigens of different types for diagnostic and therapeutic applications |
WO2007135571A2 (en) | 2006-03-23 | 2007-11-29 | Absorber Ab | Blood group antigens of different types for diagnostic and therapeutic applications |
US7897328B2 (en) | 2006-03-23 | 2011-03-01 | Absorber Ab | Blood group antigens of different types for diagnostic and therapeutic applications |
US8404456B2 (en) | 2006-03-23 | 2013-03-26 | Absorber Ab | Blood group antigens of different types for diagnostic and therapeutic applications |
US20070224652A1 (en) * | 2006-03-23 | 2007-09-27 | Jan Holgersson | Blood Group Antigens of Different Types for Diagnostic and Therapeutic Applications |
WO2007124464A2 (en) | 2006-04-20 | 2007-11-01 | Becton, Dickinson And Company | Thermostable proteins and methods of making and using thereof |
US20080009026A1 (en) * | 2006-07-07 | 2008-01-10 | Invitrogen Corporation | Fluorogenic protein kinase substrates |
US8124368B2 (en) | 2006-07-07 | 2012-02-28 | Life Technologies Corporation | Fluorogenic protein kinase substrates |
US8030401B1 (en) | 2006-08-03 | 2011-10-04 | Henkel Corporation | Photoinitiated cationic epoxy compositions |
US10845373B2 (en) | 2006-10-27 | 2020-11-24 | Life Technologies Corporation | Fluorogenic pH sensitive dyes and their method of use |
US9910051B2 (en) | 2006-10-27 | 2018-03-06 | Life Technologies Corporation | Fluorogenic pH sensitive dyes and their method of use |
EP2727965A1 (en) | 2006-10-27 | 2014-05-07 | Life Technologies Corporation | Fluorogenic pH sensitive dyes and their method of use |
US11867698B2 (en) | 2006-10-27 | 2024-01-09 | Life Technologies Corporation | Fluorogenic pH sensitive dyes and their method of use |
US7714037B1 (en) | 2006-12-15 | 2010-05-11 | Henkel Corporation | Photoinitiated cationic epoxy compositions and articles exhibiting low color |
US20090004753A1 (en) * | 2007-01-30 | 2009-01-01 | Invitrogen Corporation | Labeling reagents and methods of their use |
US9645153B2 (en) | 2007-01-30 | 2017-05-09 | Life Technologies Corporation | Labeling reagents and methods of their use |
US9140706B2 (en) | 2007-01-30 | 2015-09-22 | Life Technologies Corporation | Labeling reagents and methods of their use |
US8586743B2 (en) | 2007-01-30 | 2013-11-19 | Life Technologies Corporation | Labeling reagents and methods of their use |
EP2535423A2 (en) | 2007-02-13 | 2012-12-19 | Life Technologies Corporation | Labeling and detection of nucleic acids |
EP2224013A1 (en) | 2007-02-13 | 2010-09-01 | Life Technologies Corporation | Methods for the determination of telomerase activity using click chemistry |
US20100203564A1 (en) * | 2007-05-30 | 2010-08-12 | Life Technologies Corporation | Fluorescent Phospholipase A2 Indicators |
US8513451B2 (en) | 2007-05-30 | 2013-08-20 | Hee Chol Kang | Fluorescent phospholipase A2 indicators |
US20090030106A1 (en) * | 2007-07-23 | 2009-01-29 | Henkel Corporation | Photosensitive Compounds, Photopolymerizable Compositions Including the Same, and Methods of Making and Using the Same |
US7705064B2 (en) | 2007-07-23 | 2010-04-27 | Henkel Corporation | Photosensitive compounds, photopolymerizable compositions including the same, and methods of making and using the same |
US20100248190A1 (en) * | 2007-08-07 | 2010-09-30 | Kerr Corporation | Method of using dental composition |
EP2022464A2 (en) | 2007-08-07 | 2009-02-11 | Kerr Corporation | Gingival retraction with light curable composition |
US20090247984A1 (en) * | 2007-10-24 | 2009-10-01 | Masimo Laboratories, Inc. | Use of microneedles for small molecule metabolite reporter delivery |
US20090246441A1 (en) * | 2008-03-31 | 2009-10-01 | Nbc Universal, Inc. | System and Method for Photobleaching of Optical Media |
US20090263612A1 (en) * | 2008-04-18 | 2009-10-22 | Nbc Universal, Inc. | System and Method for Photobleaching of Optical Media |
US8488428B2 (en) | 2008-05-14 | 2013-07-16 | Nbcuniversal Media, Llc | Enhanced security of optical article |
US10138510B2 (en) | 2008-05-16 | 2018-11-27 | Life Technologies Corporation | Dual labeling methods for measuring cellular proliferation |
US20110118142A1 (en) * | 2008-05-16 | 2011-05-19 | Life Technologies Corporation | Dual labeling methods for measuring cellular proliferation |
US8243570B2 (en) | 2008-11-13 | 2012-08-14 | Nbcuniversal Media, Llc | System and method for combining pre-mastered errors with marks or printed spots on optical media |
US20100118674A1 (en) * | 2008-11-13 | 2010-05-13 | General Electric Company | System and method for combining pre-mastered errors with marks or printed spots on optical media |
WO2010099137A2 (en) | 2009-02-26 | 2010-09-02 | Osi Pharmaceuticals, Inc. | In situ methods for monitoring the emt status of tumor cells in vivo |
US8974651B2 (en) | 2010-04-17 | 2015-03-10 | C.C. Imex | Illuminator for visualization of fluorophores |
WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
EP2450024A2 (en) | 2010-11-04 | 2012-05-09 | Kerr Corporation | Dental material with color indicator and metods of using same |
US9399004B2 (en) | 2010-11-04 | 2016-07-26 | Kerr Corporation | Dental composition having a redox indicator and method of using same |
US9522099B2 (en) | 2010-11-04 | 2016-12-20 | Kerr Corporation | Dental compositions having special functionality and a tri-barrel packaging and delivery system therefor |
WO2013036502A1 (en) | 2011-09-07 | 2013-03-14 | Microchem Corp. | Epoxy formulations and processes for fabrication of relief patterns on low surface energy substrates |
US11635688B2 (en) | 2012-03-08 | 2023-04-25 | Kayaku Advanced Materials, Inc. | Photoimageable compositions and processes for fabrication of relief patterns on low surface energy substrates |
WO2014066733A2 (en) | 2012-10-25 | 2014-05-01 | Life Technologies Corporation | Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins |
US10815388B2 (en) | 2013-05-30 | 2020-10-27 | Henkel IP & Holding GmbH | Primer compositions for injection molding |
WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
EP3733244A1 (en) | 2013-10-02 | 2020-11-04 | Medlmmune, LLC | Neutralizing anti-influenza a antibodies and uses thereof |
US10542918B2 (en) | 2013-10-23 | 2020-01-28 | Verily Life Sciences Llc | Modulation of a response signal to distinguish between analyte and background signals |
US9636034B2 (en) | 2013-10-23 | 2017-05-02 | Verily Life Sciences Llc | Non-invasive analyte detection system with modulation source |
US9504405B2 (en) | 2013-10-23 | 2016-11-29 | Verily Life Sciences Llc | Spatial modulation of magnetic particles in vasculature by external magnetic field |
US11464429B2 (en) | 2013-10-23 | 2022-10-11 | Verily Life Sciences Llc | Modulation of a response signal to distinguish between analyte and background signals |
US10641731B2 (en) | 2014-04-01 | 2020-05-05 | C.C. Imex | Electrophoresis running tank assembly |
US9835587B2 (en) | 2014-04-01 | 2017-12-05 | C.C. Imex | Electrophoresis running tank assembly |
WO2016111915A1 (en) | 2015-01-06 | 2016-07-14 | De Haas Anthony H | Near-infrared fluorescent surgical dye markers |
US10383957B2 (en) | 2015-01-06 | 2019-08-20 | Anthony H. de Haas | Near-infrared fluorescent surgical dye markers |
US9861710B1 (en) | 2015-01-16 | 2018-01-09 | Verily Life Sciences Llc | Composite particles, methods, and in vivo diagnostic system |
US10028659B2 (en) | 2015-03-26 | 2018-07-24 | Verily Life Sciences Llc | Aptamer-based sensors, implantable devices and detection system |
US11697740B2 (en) | 2015-09-28 | 2023-07-11 | Henkel Ag & Co. Kgaa | Primer compositions for injection molding |
WO2017181176A1 (en) | 2016-04-15 | 2017-10-19 | Lcahn School Of Medicine At Mount Sinai | Tissue profiling using multiplexed immunohistochemical consecutive staining |
US10307940B2 (en) | 2016-05-13 | 2019-06-04 | MSI Coatings Inc. | System and method for using a VOC free low radiant flux LED UV curable composition |
US11738481B2 (en) | 2016-05-13 | 2023-08-29 | MSI Coatings Inc. | System and method for using a VOC free low radiant flux LED UV curable composition |
US20190273352A1 (en) * | 2017-03-27 | 2019-09-05 | Aptiv Technologies Limited | Sealed electric terminal assembly and method |
US10574014B2 (en) | 2017-03-27 | 2020-02-25 | Aptiv Technologies Limited | Method for sealing electric terminal assembly |
US20180278004A1 (en) * | 2017-03-27 | 2018-09-27 | Delphi Technologies, Inc. | Sealed electric terminal assembly and method |
WO2018183621A1 (en) | 2017-03-30 | 2018-10-04 | Life Technologies Corporation | Quantification of ngs dna by adapter sequence |
US10017659B1 (en) | 2017-10-09 | 2018-07-10 | Delphi Technologies, Inc | Robust sealed electric terminal assembly |
EP3467051A1 (en) | 2017-10-09 | 2019-04-10 | Aptiv Technologies Limited | Robust sealed electric terminal assembly |
US20220280970A1 (en) * | 2018-02-03 | 2022-09-08 | MSI Coatings, Inc. | Composition for aerosol cans, method of making and using the same |
US11338320B1 (en) | 2018-02-03 | 2022-05-24 | MSI Coatings Inc. | Composition for aerosol cans, method of making and using the same |
WO2022006368A2 (en) | 2020-07-02 | 2022-01-06 | Life Technologies Corporation | Trinucleotide cap analogs, preparation and uses thereof |
WO2023004400A1 (en) | 2021-07-21 | 2023-01-26 | Life Technologies Corporation | Dibenzoxanthene quenchers, uses, and methods of preparation |
Also Published As
Publication number | Publication date |
---|---|
WO1995014689A1 (en) | 1995-06-01 |
US5623080A (en) | 1997-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5451343A (en) | Fluorone and pyronin y derivatives | |
KR100976995B1 (en) | Thiol compound, photopolymerization initiator composition and photosensitive composition | |
TW421660B (en) | Acid-stable borates for photopolymerization | |
US5395862A (en) | Photooxidizable initiator composition and photosensitive materials containing the same | |
US4751102A (en) | Radiation-curable ink and coating compositions containing ionic dye compounds as initiators | |
Dumur | Recent advances on coumarin-based photoinitiators of polymerization | |
CN100528838C (en) | Oxime ester photoinitiatros having combined structure | |
US4290870A (en) | Photopolymerizable compositions | |
AU712075B2 (en) | Borate photoinitiators from monoboranes | |
US4367280A (en) | Photopolymerizable composition | |
US4713401A (en) | Titanocenes and a radiation-polymerizable composition containing these titanocenes | |
US4876175A (en) | Dye sensitized photographic imaging systems | |
ITMI962438A1 (en) | BORATE COINIZIATORS FOR PHOTOPOLYMERIZATION | |
JPH06211831A (en) | Fluorone and pyronine y | |
CA2191052A1 (en) | Borate photoinitiators from polyboranes | |
WO2000071544A1 (en) | Chromene compounds | |
US4966830A (en) | Photopolymerizable composition | |
EP0636148A1 (en) | Visible photosensitizers for photopolymerizable compositions. | |
Sun et al. | Bis‐substituted thiophene‐containing oxime sulfonates photoacid generators for cationic polymerization under UV–visible LED irradiation | |
US5998496A (en) | Photosensitive intramolecular electron transfer compounds | |
EP0624580A1 (en) | Styrylcoumarin compound, photosensitive resin composition, and hologram recording medium | |
US5492942A (en) | Pyran derivative, photosensitive resin composition, and hologram recording medium using it | |
JP2724708B2 (en) | New benzyl diketals | |
Tanabe et al. | Visible light photopolymerization: Synthesis of new fluorone dyes and photopolymerization of acrylic monomers using them | |
CN107129458B (en) | Carbazole oxime ester compound and synthesis method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SPECTRA GROUP LIMITED, INC., OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NECKERS, DOUGLAS C.;SHI, JIANMIN;REEL/FRAME:006822/0510;SIGNING DATES FROM 19931210 TO 19931213 |
|
CC | Certificate of correction | ||
CC | Certificate of correction | ||
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20030919 |